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ABSTRACT
Electrophysiological Endophenotypes in Autism Spectrum Disorder:
A Family Study
Ann Clawson
Department of Psychology, BYU
Doctor of Philosophy
Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorder
associated with altered neural connectivity and deficits in self-monitoring, response inhibition,
and planning. One promising avenue of research to improve understanding of the symptoms and
heritable nature of ASD may be the identification of neural endophenotypes of ASD. The errorrelated negativity (ERN) and post-error positivity (Pe), scalp-recorded event-related potentials
(ERPs), reflect performance monitoring processes and may qualify as candidate endophenotypes
of ASD. We collected ERP and behavioral data (error rates, response times) from 18 ASD
probands and their families (mother, father, sibling) and 38 control youth and their parents to
examine the utility of the ERN and Pe as endophenotypes of ASD. In order to examine
differences based on group (ASD vs. control) and kinship (proband, sibling, mother, father), we
conducted separate multiple regression analyses on behavioral and ERP data with group and
kinship as predictors and families as clusters. We hypothesized that ASD probands would
display reduced-amplitude ERN and impaired behavioral performance relative to control youth
but no differences in Pe amplitude and that families of ASD probands would display reduced
error minus correct (ΔERN) amplitudes and impaired behavioral performance relative to control
families but no differences in ΔPe amplitude. We did not observe significant ERN amplitude
group differences among ASD probands relative to control youth. Likewise, control youth did
not differ from ASD probands on behavioral measures or Pe amplitudes. Analyses by family
revealed that group and kinship did not significantly predict ΔERN amplitudes. However,
fathers of ASD probands displayed significantly reduced ΔPe amplitudes relative to control
fathers and parents displayed significantly larger ΔPe amplitudes and better performance than
youth. Together, results do not provide sufficient evidence to support the ERN or Pe as an
endophenotype or biomarker of ASD. These findings add to an overall heterogeneous literature
on performance monitoring in ASD and point to the need for additional research to understand
the state-related or trait-related factors that may contribute to ERN amplitudes in ASD.

Keywords: autism spectrum disorder, error-related negativity, post-error positivity,
endophenotype
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1
Electrophysiological Endophenotypes in Autism Spectrum Disorder:
A Family Study
Autism spectrum disorder (ASD) is a pervasive developmental disorder characterized by
a constellation of psychological, cognitive, and neural symptoms. Diagnosis of ASD is based on
the presence of social interaction impairments, including poor social and emotional reciprocity;
communication deficits, often manifest in language delays or poor use of nonverbal
communication; and inflexible, repetitive, or stereotypical behaviors (American Psychiatric
Association, 2013). However, it is yet unclear why these symptoms co-occur and the functional
impact and degree to which specific symptoms are present is heterogeneous across individuals
on the autism spectrum (Minshew & Williams, 2007). Individual differences in symptom
presentation are associated with substantial variability within the diagnosis of ASD, contributing
to difficulty establishing meaningfully discriminatory diagnostic criteria that account for severity
and differences in symptom presentation (Viding & Blakemore, 2007). As a result, research is
needed to improve our understanding of the factors that contribute to ASD in order to guide
diagnosis and treatment and establish distinct divisions among symptoms (Happé, Ronald, &
Plomin, 2006; Liu & Takumi, 2014).
Neural Abnormalities in ASD
Current theories suggest that impaired neural communication caused by abnormal whitematter connectivity may underlie the symptoms of ASD (Barnea-Goraly, Lotspeich, & Reiss,
2010; Belmonte et al., 2004; Griebling et al., 2010; Haznedar et al., 2000; Just, Cherkassky,
Keller, Kana, & Minshew, 2007; Wass, 2011). Functional neuroimaging studies reveal shortrange white matter over-connectivity (Belmonte et al., 2004; Orekhova et al., 2007; Wass, 2011)
coupled with impaired long-range connectivity between neural networks (Anderson et al., 2011;
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Just et al., 2007; Kana, Keller, Minshew, & Just, 2007; Zikopoulos & Barbas, 2010), possibly
initiated by early brain overgrowth (Belmonte et al., 2004; Courchesne et al., 2011; Redcay &
Courchesne, 2005; Wass, 2011). Altered connectivity may result in inadequate integration of
information between brain regions, resulting in overall neural inefficiency during complex,
higher-level social and cognitive processes (Kana, Libero, & Moore, 2011; Minshew &
Williams, 2006; Wass, 2011).
Studies suggest a link between abnormal connectivity and the social, communication, and
restricted/repetitive behaviors of ASD. For example, disrupted limbic connectivity within the
uncinate fasciculus and frontal and temporal thalamic projections is tied to impairments in socioemotional functioning (Ameis & Catani, 2015) and increased corticostriatal functional
connectivity is associated with difficulties in social interaction and communication as well as
restricted interests/repetitive behaviors (Delmonte, Gallagher, O'Hanlon, McGrath, & Balsters,
2013). Abnormal connectivity in ASD may lead to deficits in higher-level cognitive functions,
such as theory of mind and executive functioning (Cheng, Rolls, Gu, Zhang, & Feng, in press;
Christ, Kester, Bodner, & Miles, 2011; Just et al., 2007; Ozonoff, Pennington, & Rogers, 1991).
Taken together, though disrupted neural connectivity is clearly implicated in the symptoms of
ASD, the location and extent of disrupted connectivity is variable, as is the developmental
course, possibly influencing the extensive heterogeneity in symptom presentation and severity in
individuals with ASD (Viding & Blakemore, 2007).
The Genetics of ASD
Heritability studies suggest that ASD is the most heritable neurodevelopmental disorder
(Bailey et al., 1995; Hallmayer et al., 2011), with estimates of up to 80% heritability
(Lichtenstein, Carlström, Råstam, Gillberg, & Anckarsäter, 2010; Losh, Sullivan, Trembath, &
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Piven, 2008) and concordance rates among monozygotic twins estimated at 70-90% compared to
10-30% in dizygotic twins (Bailey et al., 1995; Rosenberg et al., 2009). In addition, family
members of affected individuals are 24 to 40 times more at risk for developing ASD than
families without a history of ASD (Losh et al., 2008; Ozonoff et al., 2011). Even if they do not
receive a formal diagnosis, unaffected family members of ASD probands (i.e., the affected
individual) often display milder symptoms of ASD themselves, identified as the broader autism
phenotype. Though findings are somewhat mixed (Hallmayer et al., 2011; Ronald & Hoeksma,
2010), additive genetic factors (i.e., the cumulative affect of variability in allelic genetic
expression) may have a larger influence on ASD symptoms than non-shared environmental
factors (Colvert et al., in press; Klei et al., 2012). The strong influence of genetic factors on
ASD symptom presentation has also been observed among those with subclinical symptoms,
suggesting genetic liability exists across severity levels of ASD symptomology (Colvert et al., in
press). Thus, studies of heritability consistently indicate that genetics play a critical role in
contributing to both clinical and subclinical symptoms of ASD.
Autism spectrum disorder is clearly heritable, but does not follow typical Mendelian
patterns of inheritance and researchers have identified hundreds of genetic loci and chromosomal
abnormalities tied to the disorder (Betancur, 2011; Gaugler et al., 2014; Li, Zou, & Brown,
2012). Many of the genetic variants implicated in ASD are involved in regulating general
neuronal functioning, reinforcing the role of abnormal neuronal development in ASD (Liu &
Takumi, 2014). For example, genome wide association studies (GWAS) have identified genetic
loci involved in regulating synaptic membrane exocytosis (Kumar et al., 2010), binding amyloid
and CREB precursor proteins (Barnby et al., 2005; Sutcliffe, Han, Amin, Kesterson, & Nurmi,
2003), regulating NMDA and glutamate receptors, and several other critical functions (see Li et
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al., 2012 for a full review). Given that the genes currently tied to ASD are associated with
general neural functions rather than specific processes it is unclear to what degree these genes
influence specific symptomatic and neural outcomes. It may be that rare mutations contribute to
liability for ASD diagnosis, but that common variation in genes (such as those noted above)
explain a larger proportion of the heritability of ASD (Gaugler et al., 2014). Therefore, the
unique functional consequences (e.g., stereotypical behaviors, impaired communication, etc.) of
ASD are likely the result of complex gene-environment and gene-gene interactions that occur
throughout the course of development (Betancur, 2011; Eapen, 2011; Hallmayer et al., 2011;
Kiser, Rivero, & Lesch, 2015; Liu & Takumi, 2014; Risch et al., 1999).
Endophenotypes: Bridging Genes and Behavior
Given the heterogeneous symptom presentation and neural and genetic complexity of
ASD, a key issue in ASD research is the identification of easily measurable processes that
mediate genotype-behavior relationships. Researchers have suggested the utility of cognitive or
neural endophenotypes as a way to link genes and behavior and better understand the nature of
ASD (Bosl, Tierney, Tager-Flusberg, & Nelson, 2011; Glahn, Thompson, & Blangero, 2007;
Gottesman & Gould, 2003; Jeste & Nelson, 2009). According to National Institutes of Health
Research Domain Criteria (RDoC) policy, endophenotypes are “relatively well-specified
physiological or behavioral measures that are considered to occupy the terrain between disease
symptoms and risk genotypes” (Insel & Cuthbert, 2009, p. 988). In other words,
endophenotypes are internal processes (i.e., generally unobservable to the naked eye) that
mediate gene-behavior pathways (Gottesman & Gould, 2003; Viding & Blakemore, 2007).
Neuropsychological processes, cognitive measures, psychometric patterns, and patterns of neural
activation have all been proposed as potential endophenotypes given that they are tied to genetic
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causes but also contribute to symptom presentation (Miller & Rockstroh, 2013). It is important
to note that although endophenotypes are conceptualized as meditational processes, they do not
represent another level in a causal chain leading from genes to behavior. Rather,
endophenotypes are a part of a causal network wherein disruption at one level can, by
association, have an impact at other levels, influencing the etiology of a disorder (Cannon &
Keller, 2006; Miller & Rockstroh, 2013). In this way, endophenotypes integrate psychological,
biological, physiological, and genetic information (Viding & Blakemore, 2007) and may
improve understanding of gene-behavior relationships by providing insight into possible
mechanisms through which disorders occur (Glahn et al., 2007; Viding & Blakemore, 2007).
The use of endophenotypes may be particularly advantageous in ASD research by
providing a way to link heterogeneity between behavioral presentation and genetic factors
(Eapen, 2011; Jeste & Nelson, 2009). The current state of ASD research clearly indicates the
complexity of the gene-behavior relationship, as no one factor has been identified as a primary
cause of ASD symptoms. The conceptualization of endophenotypes is in-line with individual
variability evident in ASD research, as it assumes that psychopathology is complex and the result
of multi-faceted, reciprocal and recursive relationships that occur throughout development
(Miller & Rockstroh, 2013). Additionally, endophenotypes may provide a way to identify
homogeneous subgroups among those with ASD (de Geus, 2010; Eapen, 2011; Viding &
Blakemore, 2007) or provide a sensitive measure of susceptibility in relatives without overt signs
of the disorder (Viding & Blakemore, 2007). Again, because the definition of an endophenotype
assumes a multi-causal network rather than one individual contributor (Miller & Rockstroh,
2013), endophenotypes may facilitate greater differentiation of the unique contributors that
underlie ASD symptoms but result in individual symptom profiles. Thus, the identification of

6
endophenotypes is a critical step in building on previous research to advance our understanding
of ASD.
Several criteria have been established for behaviors or neural activity to qualify as an
endophenotype. A candidate endophenotype must be: 1) associated with a disorder, 2) heritable,
3) manifest independent of illness state (e.g., uniform before and after treatment), 4) co-occur
with the disorder in families, and 5) present in the same form within families of affected
individuals to a larger degree than the general population (Gottesman & Gould, 2003; Olvet &
Hajcak, 2008). These criteria differentiate endophenotypes from biomarkers, as they imply that
a potential endophenotype is more than a correlate with the disorder, is clearly heritable, and is
not merely a state-dependent outcome with limited replicability (Gould & Gottesman, 2006;
Miller & Rockstroh, 2013; Ritsner & Gottesman, 2009). A biomarker, on the other hand, detects
pathophysiological features of a disorder but may not be tied to underlying genetic causes
(Ritsner & Gottesman, 2009).
Electrophysiological endophenotypes. Recently, researchers have suggested the utility
of event-related potentials (ERPs) as neural endophenotypes (de Geus, 2010; Glahn et al., 2007;
Olvet & Hajcak, 2008). Event-related potentials are time locked markers of neural activity as
measured by scalp-recorded electroencephalogram (EEG). Substantial evidence suggests that
ERPs are heritable and thus stem from genetic processes (for a review, see de Geus, 2010). Due
to the high temporal resolution of EEGs, ERPs can be used to signify specific cognitive,
behavioral, and motor responses to internal processes or external stimuli (de Geus, 2010). Thus,
ERPs are easily measurable indices that reveal information regarding the timing and processing
stage impacted by a specific disorder (de Geus, 2010). In this way ERPs are ideal potential
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endophenotypes, as they are influenced by genetics but are also directly tied to cognitive and
neural processes.
ERN. One promising candidate for use as an endophenotypic marker in ASD is the errorrelated negativity (ERN; Olvet & Hajcak, 2008), an ERP associated with cognitive control and
performance monitoring processes (Falkenstein, Hohnsbein, Hoormann, & Banke, 1991;
Gehring, Goss, Coles, Meyer, & Donchin, 1993; Yeung, Botvinick, & Cohen, 2004). The ERN
is a fronto-central negativity that appears approximately 50-100ms following an error response
(Gehring et al., 1993; Yeung et al., 2004). Source localization studies suggest that the ERN is
associated with activity in the anterior cingulate cortex (ACC) and may involve communication
with several brain regions within the prefrontal cortex to facilitate top-down control (Bush, Luu,
& Posner, 2000; Carter et al., 1998; van Veen & Carter, 2002a).
Several theories have been proposed to explain ERN generation (see Larson, Clayson, &
Clawson, 2014 for a review). The conflict monitoring theory suggests that the ERN may
represent response conflict between competing correct and incorrect responses (Botvinick,
Carter, Braver, Barch, & Cohen, 2001; Yeung et al., 2004). From this perspective, the ERN is a
reflection of performance monitoring processes used to evaluate contextual information to
monitor and regulate goal-directed behaviors (Botvinick et al., 2001; Yeung et al., 2004; Yeung
& Cohen, 2006). Alternatively, the ERN may represent a signal of error awareness when the
expected correct response is inconsistent with the erroneous response that was selected
(Falkenstein et al., 1991; Falkenstein, Hoormann, Christ, & Hohnsbein, 2000). The
reinforcement learning theory of the ERN considers the role of dopamine in ERN generation,
suggesting that the ERN is a signal that results from phasic dips in dopamine following an error
(Holroyd & Coles, 2002). These decreases in dopamine result in disinhibition of the ACC,
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signaling that an unexpected outcome has occurred and behavioral modification is required to
improve performance in the future (Holroyd & Coles, 2002). Finally, the ERN may be more
closely tied to affective responses when a motivationally salient outcome does not occur, with
enhanced ERN amplitudes reflecting increased neural activity due to the aversive nature of an
error (Chiu & Deldin, 2007; Proudfit, Inzlicht, & Mennin, 2013; Vidal, Hasbroucq, Grapperon,
& Bonnet, 2000). Common among all of these theories is the underlying theme that enhanced
ERN amplitudes are associated with activation of cognitive and affective processes involved in
recognizing and utilizing contextual information following errors to then regulate performance
and avoid error commission in the future (Olvet & Hajcak, 2008; South, Larson, Krauskopf, &
Clawson, 2010).
Pe. The post-error positivity (Pe) is a positive-going ERP that typically co-occurs with
the ERN. The Pe appears within 200-500ms of error commission and is typically more
posteriorly located than the ERN, possibly representing activation in the rostral or dorsal ACC
(Bush et al., 2000; Herrmann, Römmler, Ehlis, Heidrich, & Fallgatter, 2004; Overbeek,
Nieuwenhuis, & Ridderinkhof, 2005; van Veen & Carter, 2002b). Most research on the Pe
suggests that it signifies error awareness or detection (Hajcak, McDonald, & Simons, 2004;
Nieuwenhuis, Ridderinkhof, Blom, Band, & Kok, 2001; Steinhauser & Yeung, 2010), with
larger amplitudes following trials in which individuals were aware of error commission (Endrass,
Reuter, & Kathmann, 2007; O’Connell et al., 2009), though some inconsistencies have been
observed (Herwig, Baumgartner, Kaffenberger, & Brühl, 2007). Most studies indicate a
dissociation between the ERN and Pe, as the Pe purportedly acts more directly as an error signal
utilized to initiate behavior change than the ERN (Nieuwenhuis et al., 2001). Thus, the ERN and
Pe signify separate but related phases of the performance monitoring process.
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The ERN and Pe as potential endophenotypes. Current research indicates that the
ERN, but not the Pe, may qualify as an endophenotype of psychopathology (Olvet & Hajcak,
2008; Proudfit et al., 2013). Of note, considerably more research has been conducted on the
ERN than the Pe in relation to the above criteria for a candidate endophenotype, with greater
variability in findings related to the Pe. Research regarding the first criteria as an endophenotype
suggests that ERN amplitude differences are associated with pathology such as depression,
anxiety, obsessive-compulsive disorder (OCD), and, most importantly, ASD (Chiu & Deldin,
2007; Endrass, Klawohn, Schuster, & Kathmann, 2008; Hajcak, Franklin, Foa, & Simons, 2008;
Hajcak, McDonald, & Simons, 2003; Henderson et al., 2006; Ruchsow et al., 2005; South et al.,
2010). Research on the Pe is less consistent, with some studies indicating no significant group
differences among individuals with OCD and depression relative to control participants (Chiu &
Deldin, 2007; Endrass et al., 2010; Ruchsow et al., 2005) while another study indicated
significantly reduced ΔPe (error minus correct trial Pe) among individuals with MDD relative to
controls (Olvet, Klein, & Hajcak, 2010). Supporting the second criteria as an endophenotype,
heritability estimates of both the ERN and Pe approach .50, implying that these waveforms are
linked to genetic factors (Anokhin, Golosheykin, & Heath, 2008). Additionally, multivariate
analyses revealed genetic overlap of more than 50% for the ERN and Pe, suggesting that they
stem from similar genetic influences (Anokhin et al., 2008). Finally, in support of the third
criteria, ERN amplitude differences remain stable after treatment, suggesting that the ERN
remains constant regardless of illness state (Hajcak et al., 2008; Olvet & Hajcak, 2008). The Pe,
however, changed among adults with ADHD following mindfulness-based cognitive therapy,
with significantly increased Pe amplitudes putatively indicative of greater global cognitive and
affective self-awareness (Schoenberg et al., 2014). Together, the ERN appears to meet the first
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three criteria as an endophenotype, but research regarding the Pe suggests that it is not
consistently associated with psychopathology and may not be reliable indicator of disease-related
processes.
Relatively few studies to date have examined the fifth criteria of an endophenotype, or
whether ERN or Pe amplitude differences exist in unaffected first-degree family members. The
few existing studies reveal similar patterns of ERN activation among probands and relatives of
affected individuals compared to controls, providing compelling evidence that the ERN may
serve as a useful endophenotype. For example, enhanced ERN amplitudes observed in OCD
probands were also observed in siblings of individuals with OCD (Carrasco et al., 2013; Riesel,
Endrass, Kaufmann, & Kathmann, 2011), reduced-amplitude ERN associated with substance use
disorders were also observed among children whose parents had a substance use disorder (Euser,
Evans, Greaves-Lord, Huizink, & Franken, 2012), reduced-amplitude ERN was seen in relatives
of individuals with schizophrenia and probands (Simmonite et al., 2012), and reduced-amplitude
ERN seen in ADHD probands were also observed among unaffected relatives (Albrecht et al.,
2008; McLoughlin et al., 2009). In contrast, no difference in Pe amplitude was observed in
relatives of probands with ADHD or schizophrenia (Albrecht et al., 2008; McLoughlin et al.,
2009; Simmonite et al., 2012). Based on the current research, the ERN, but not the Pe, meets the
fifth criteria of an endophenotype, as it appears to be present in the same from within families of
affected individuals.
The methodology utilized within these studies of family and heritability and ERPs is
variable, limiting the interpretability of the role of kinship (e.g., whether the individual is a
sibling or parent) in ERN and Pe generation. For example, in the abovementioned studies of
OCD and ADHD, affected individuals and “relatives” were either not related (McLoughlin et al.,

11
2009; Riesel et al., 2011) or were related in some but not all sibling pairs (Carrasco et al., 2013;
Simmonite et al., 2012). Further, Euser et al. (2012) only included relatives without the
comparison of affected probands. Only the study by Albrecht et al. (2008) examining children
with ADHD included a full sample of related sibling pairs. Thus, although these studies suggest
that the ERN may serve as a marker of susceptibility among unaffected relatives, no studies have
examined ERN amplitudes within families of affected probands who also participated in the
study. Full family studies are requisite to better understand how the ERN mediates the genesymptom relationship.
The ERN as an endophenotype of ASD. Given the utility of endophenotypes in
bridging the genetic and symptom/behavioral heterogeneity of ASD, it may be beneficial to
examine the ERN as a potential endophenotype of ASD. As detailed below, there is some
evidence that the ERN may qualify as a candidate endophenotype of ASD. The heritable nature
of the ERN and relationship with neural and cognitive processes further support the ERN as an
endophenotype of ASD, as the ERN may provide a way to link heterogeneity of symptoms in a
way that accounts for genetic, neural, and cognitive aspects of ASD.
ERN in ASD. Research examining the ERN in individuals with ASD reveals significantly
attenuated ERN amplitudes relative to typically developing controls (TDCs), putatively implying
a reduced ability to evaluate conflicting information (Sokhadze et al., 2010; Sokhadze et al.,
2012; South et al., 2010; Vlamings, Jonkman, Hoeksma, van Engeland, & Kemner, 2008).
Imaging studies during cognitive control tasks reveal that the implementation of cognitive
control required for response monitoring by the ACC may be impaired due to compromised
neural structure (Simms, Kemper, Timbie, Bauman, & Blatt, 2009) and reduced connectivity
between the ACC and both long-distance and neighboring brain regions such as the prefrontal
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cortex (Agam, Joseph, Barton, & Manoach, 2010; Anderson et al., 2011; Courchesne et al.,
2011; Thakkar et al., 2008; Zikopoulos & Barbas, 2010). Together, these studies suggest that
cognitive control impairments in ASD are potentially tied to neural irregularities in the ACC and
its concomitant connections.
Other studies of the ERN in individuals with ASD reveal inconsistent differences
between ASD youth and TDCs. Groen et al. (2008) observed no differences in ERN amplitudes
among children with sub-threshold symptoms of ASD relative to TDCs and children with
ADHD. In contrast, larger ERN amplitudes were observed among children with ASD with
higher VIQ scores relative to TDC children (Henderson et al., 2006). More recent research adds
to these studies by suggesting that individual characteristics may play a critical role in
contributing to ERN generation in ASD. For example, although no group differences were
observed in ERN amplitudes between youth with ASD relative to TDCs, larger ERN amplitudes
were associated with greater severity of parent-reported symptoms of ASD (McMahon &
Henderson, 2014). Similarly, ΔERN (the difference between ERN amplitudes on correct and
error trials) amplitude differences between youth with ASD and TDC youth were not observed
during a basic facial processing task, but larger ΔERN amplitudes were observed during a more
complex task, possibly suggesting reduced processing efficiency in ASD in complex social
contexts (McMahon & Henderson, 2014). In sum, the majority of studies indicate differences in
ERN amplitudes between youth with ASD and TDCs, though individual differences may play a
critical role in mediating and/or moderating ERN amplitude differences.
Pe in ASD. Research on the Pe in individuals with ASD is limited but overall reveals no
significant Pe differences among individuals with ASD relative to TDCs. Across four separate
studies, children and adults with ASD displayed no significant differences in Pe amplitude
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(Groen et al., 2008; Santesso et al., 2011; Sokhadze et al., 2010; South et al., 2010). Only one
study by Vlamings et al. (2008) revealed significantly reduced-amplitude Pe in ASD compared
to TDCs, possibly indicative of overall reduced error awareness or allocation of attention to
errors. Taken together, the bulk of the current research on the Pe in ASD points to intact neural
indices of error awareness.
Performance monitoring in unaffected relatives. The nature of performance monitoring
in family members of ASD probands remains largely unexplored, as no studies to date have
examined ERN amplitudes in relatives of ASD probands. Nevertheless, there is substantial
evidence of genetic liability in family members, supporting the possibility of the ERN as a neural
endophenotype. Unaffected relatives display impairments in joint attention, communication, and
social interaction (Bishop, Maybery, Wong, Maley, & Hallmayer, 2006; Dawson et al., 2002;
Ruser et al., 2007; Sucksmith, Roth, & Hoekstra, 2011; Sumiyoshi, Kawakubo, Suga,
Sumiyoshi, & Kasai, 2011). Cognitively, family members also display deficits in planning
(Delorme et al., 2007; Nydén, Hagberg, Goussé, & Rastam, 2011; Ozonoff, Rogers, Farnham, &
Pennington, 1993) and the ability to organize information (Sumiyoshi et al., 2011), although
other studies report no significant differences in these areas (Sucksmith et al., 2011; Wong,
Maybery, Bishop, Maley, & Hallmayer, 2006). Likewise, on tasks assessing several different
domains of functioning, researchers have observed commonalities in neural activation between
ASD probands and their relatives, including gray matter volume increases and decreases,
atypical frontal activation, lack of expected neural differentiation to congruent and incongruent
biological actions, and increased trait-related neural activity (Ahmed & Vander Wyk, 2013;
Belmonte, Gomot, & Baron-Cohen, 2010; Kaiser et al., 2010; Peterson et al., 2006). As a whole,
studies of neural activation and cognitive variables in non-affected family members suggest the
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presence of similar global cognitive and neural deficits observed in ASD probands. It is unclear
whether differences in ERN amplitude are reflective of cognitive or neural impairments resulting
from ASD or whether differences in ERN amplitude represent heritable markers tied to a genetic
predisposition for ASD (de Geus, 2010).
In sum, the ERN may qualify as an endophenotype of ASD. Current ERP research
suggests that differences in ERN amplitude among individuals with ASD may be tied to
cognitive and neural deficits that underlie the symptoms of the disorder. As a result, the ERN
appears to meet the first criteria for an endophenotype of ASD. The heritable nature of the ERN
and ASD suggest that the ERN may also account for genetic commonalities that are associated
with neural abnormalities and symptom presentation in individuals with ASD. Evidence that the
underlying neural structures and cognitive functions signified by the ERN are altered in ASD
probands and families of individuals with ASD further supports a putative relationship between
ERN amplitudes and genes associated with ASD. Thus, in the current study, we sought to
determine whether the ERN qualifies as an endophenotype of ASD by measuring neural
activation during performance monitoring processes ASD probands, non-affected relatives of
ASD probands, and control families. Identifying easily measurable endophenotypes of ASD is
an important step in understanding the gene-behavior relationship of ASD, as it may lend insight
into causal networks that underlie symptom presentation (de Geus, 2010). Greater understanding
of these factors can lead to improved diagnostic classification and treatment specificity. Further,
though the focus of this project is specific to ASD, identifying the utility of the ERN as an
endophenotype will benefit research on other psychological disorders and extend knowledge of
the utility of ERPs. The specific aims and hypotheses of this study are presented below.
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Specific Aims and Hypotheses
Aim 1: To identify the presence of subthreshold symptoms of ASD in unaffected
relatives of ASD probands compared to control families.
Hypothesis 1: Guided by past research (Sucksmith et al., 2011), we predicted that unaffected
family members of ASD probands would display a higher degree of ASD symptoms than control
families as manifest by measures of ASD symptoms and the broader autism phenotype. Further,
we predicted that differences in ASD symptoms would be present based on kinship status (i.e.,
whether the participant is a mother, father, or sibling), with ASD siblings showing the highest
level of subthreshold symptoms, followed by fathers of ASD probands and mothers of ASD
probands.
Aim 2: To replicate previous findings that youth with ASD display reduced performance
monitoring ERPs relative to TDC youth (Sokhadze et al., 2010; Sokhadze et al., 2012; South et
al., 2010; Vlamings et al., 2008) and examine whether dysfunctional behavioral [error rates and
response times (RTs)] and ERP (e.g., ERN) markers of performance monitoring were evident in
parents and siblings of ASD probands to a greater degree than control families.
Hypothesis 1: ASD probands would display reduced-amplitude ERN and decreased behavioral
modification (longer RTs on error trials, greater error rates) relative to TDC youth, replicating
previous research indicating that the ERN meets the first criteria as a potential endophenotype of
ASD (Sokhadze et al., 2010; Sokhadze et al., 2012; South et al., 2010; Vlamings et al., 2008).
Groups would not differ in Pe amplitude.
Hypothesis 2: ERN amplitudes would differ based on family and kinship status (i.e., whether the
subject is a mother, father, sibling, or proband). Families of ASD probands would display
similar electrophysiological and behavioral patterns as seen in ASD probands (i.e., less negative
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ERN amplitudes), indicating that irregular ERN amplitudes and impaired behavioral responses
were evident to a greater degree in unaffected relatives of youth with ASD. Pe amplitudes would
not differ based on group or kinship status.
Hypothesis 3: Increased levels of ASD symptomology would be associated with a greater degree
of electrophysiological and behavioral impairment in performance monitoring, solidifying that
these impairments were associated with ASD.
Method
Participants
The Brigham Young University Institutional Review Board (IRB) approved all study
procedures. After complete description of the study to subjects, written informed consent was
obtained. Autism spectrum disorder probands and participating families of ASD probands were
recruited from referrals to the Brigham Young University Comprehensive Clinic, community
advertisement, and (with previous consent provided) an existing research participant pool of
individuals with ASD. Control families were recruited via advertisement throughout the local
community and Brigham Young University campus.
For our study purposes we collected data from biological family members that included a
male ASD proband or a male TDC, along with the youths’ mother, father, and one male sibling
(see Figure 1). All youth participants were males between the ages of 10 and 17 years, native
English speakers, and had a gestation over 34 weeks. We chose to include only male ASD
probands, ASD siblings, and TDCs as studies indicate potential sex differences in the amplitude
of the ERN and other cognitive control ERPs (Clayson, Clawson, & Larson, 2011; Larson,
South, & Clayson, 2011; Moser, Moran, Schroder, Donnellan, & Yeung, 2013). Also, the sex of
the proband may not increase the risk that siblings will receive a diagnosis of autism or the
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broader autism phenotype (Goin-Kochel, Abacchi, & Constantino, 2007; Ozonoff et al., 2011;
Pickles et al., 2000), decreasing the likelihood that selecting only males biased our results.
However, there is evidence of increased risk for ASD diagnosis or the broader autism phenotype
in male siblings compared to female siblings (Ozonoff et al., 2011; Piven et al., 1990; Szatmari
& Jones, 1998), thus enhancing our ability to detect subthreshold symptoms of autism by only
including male participants. We chose to use only children over age 10 in order to reduce agerelated differences in cognitive processing between siblings. Several studies indicate that
inhibitory control systems are not fully developed until age 10, at which time children begin to
perform more similar to adults (Ridderinkhof, van der Molen, Band, & Bashore, 1997; Rueda et
al., 2004).

Figure 1. Study design.
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Initial study enrollment included 180 participants from 42 families. For a full summary
of participant dropout and exclusion, see Figure 2. Ultimately, there were 148 participants who
met full inclusion criteria (73 ASD probands/relatives, 75 TDCs/relatives). Of those who met
full inclusion criteria, 134 participants (61 ASD probands/relatives, 73 TDCs/relatives) had full
data for both behavioral (i.e., RT and error rate data) and ERP measures. One sibling of an ASD
proband did not have behavioral data due to computer malfunction in behavioral recording and
eight participants (six ASD probands/relatives, two controls) did not have ERP data due to the
commission of six or fewer error trials or excessive noise artifact (Olvet & Hajcak, 2009b).
Demographic information for youth and adult participants as a function of ASD and proband
status is in Tables 1 and 2.

Figure 2. Participant flowchart.
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Table 1
Summary Demographic and Neuropsychological Data for Youth Groups
ASD Probands

ASD Siblings

Control Youth

M

SD

Range

M

SD

Range

M

SD

Range

Age

13.50

1.38

11-16

12.13

1.93

10-16

12.66

2.16

10-17

FSIQ

105.72

15.79

76-140

113.19

11.68

79-128

111.84

9.06

86-132

VIQ

102.11

17.01

72-137

110.13

9.65

88-128

110.58

10.80

85-135

PIQ

108.61

13.53

86-133

114.19

14.81

76-136

110.87

9.63

91-129

13.06

3.64

6-19

14.38

3.42

10-21

15.26

3.67

7-25

DS Standard

6.41

3.12

1-11

8.13

3.20

3-15

8.60

3.17

1-16

TMT A Raw4

26.59

6.16

17-37

29.40

7.69

17-44

26.89

8.53

13-50

TMT B-Raw

84.85

59.78

33-300

73.15

25.38

48-137

75.52

47.40

28-300

SCARED

19.87

13.11

4-41

10.46

10.32

0-38

6.66

5.84

0-25

ADOS-G

12.89

3.79

7-21

-

-

-

-

-

-

SCQ

18.67

6.62

7-34

2.77

2.28

0-7

3.34

2.32

0-8

SRS

77.56

8.52

63-98

48.33

11.36

38-72

45.24

6.33

37-64

AQ

-

10.08

6.91

0-25

11.97

5.13

3-30

Measure

DS Raw3

-

-

Note. FSIQ = full scale intelligence quotient, VIQ = verbal intelligence quotient, PIQ =
perceptual intelligence quotient, DS = Digit Span, TMT = Trail Making Test, SCARED = Screen
for Child Anxiety Related Disorders, ADOS-G = Autism Diagnostic Observation ScheduleGeneric, SCQ = Social Communication Questionnaire, SRS = Social Responsiveness Scale, AQ
= Autism Spectrum Quotient.
3

We utilized the Digit Span subtest from the Wechsler Memory Scales, 3rd Edition for all adult

and child participants. As a result, age-based norms were not available for children under 16. We
utilized norms from the Wechsler Intelligence Scale for Children, 4th Edition to approximate
standard scores for youth below age 16.
4

The adult version of the TMT A and TMT B was utilized for youth and parents.
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Table 2
Summary Demographic and Neuropsychological Data for Adult Groups
ASD Fathers
Measure

M

SD

Age

42.50

4.73

37-51

Education

15.81

3.15

12-22

Range

ASD Mothers
M

SD

Range

40.00

4.12

34-49

15.65

2.29

Control Fathers
M

SD

Range

44.37

6.56

36-56

12-20

17.90

2.83

12-25

FSIQ

117.13

9.20 100-130

112.67

8.89

98-126

120.58

VIQ

110.67

8.65

95-125

108.22 10.81

92-127

116.79 10.53

PIQ

120.40 11.87

99-136

114.22

120.05

8.09 100-127

8.93 101-133

Control Mothers
M

SD

Range

41.83

5.46

33-51

15.11

1.71

11-18

114.72

8.07 100-133

93-131

111.67

8.12

9.20

99-136

114.33

8.18 101-131

98-133

DS-Raw

19.13

4.84

11-27

16.39

2.77

12-22

20.22

4.26

13-27

17.87

3.19

13-25

DS Standard

11.67

3.42

6-17

9.56

1.85

7-14

12.61

2.91

7-17

10.18

2.30

7-16

TMT A Raw

21.47

4.49

15-31

19.15

5.58

13-31

22.23

7.15

13-41

18.77

5.41

12-28

TMT A T-Score

54.47

7.19

43-68

57.76 11.67

41-78

55.67 11.98

35-80

62.53 11.63

46-89

TMT B Raw

50.63 13.53

30-72

45.63 14.77

28-75

49.16 19.31

31-108

45.36 14.43

28-75

TMT B T-Score

54.33

9.22

41-70

55.24 10.17

38-75

56.06 11.07

30-72

58.53

9.60

38-73

6.44

5.54

0-17

4.94

4.53

0-15

4.74

4.68

0-17

7.22

7.28

0-22

STAI-State

32.67

8.87

20-50

28.71

7.40

20-43

26.16

6.19

20-42

29.22

8.29

20-49

STAI-Trait

35.56

8.88

22-48

33.88

8.60

20-52

32.16

6.48

23-49

34.78 10.67

20-59

SRS-II

48.00

7.05

37-61

44.27

5.70

36-55

41.61

6.23

36-65

44.12

5.67

38-54

AQ

16.25

6.63

9-32

12.41

6.97

6-33

44.37

6.56

9-26

13.94

5.47

5-25

BDI

BAPQ

2.60

0.66 1.19-3.42

2.39

0.74 1.61-4.42

2.57

0.58 1.72-3.64

2.45

0.42 1.72-3.11

(continued)
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Note. FSIQ = full scale intelligence quotient, VIQ = verbal intelligence quotient, PIQ = perceptual intelligence quotient, DS = Digit
Span, TMT = Trail Making Test, BDI = Beck Depression Inventory, STAI = State-Trait Anxiety Inventory, SRS = Social
Responsiveness Scale, AQ = Autism Spectrum Quotient, BAPQ = Broader Autism Phenotype Questionnaire.
No control families reported a first-degree relative with ASD and no parents or siblings of ASD probands reported a suspected
or formal diagnosis of an ASD. Several participants had neurological conditions, including one control mother with multiple
sclerosis, one mother of an ASD proband with stroke, one ASD sibling with apraxia, and one TDC youth with a history of skull
fracture. In addition, 28 participants reported previous psychological diagnoses, including 13 ASD probands, 5 ASD siblings, 2
TDCs, 4 mothers of ASD probands, 3 fathers of ASD probands, and 1 control mother. A chi-square test examining psychological
diagnosis (any diagnosis, no diagnosis) x Group (ASD proband, ASD sibling, TDC youth, mother of an ASD proband, father of an
ASD proband, control mother, control father) indicated significant group differences in the presence of a psychological diagnosis (χ2 =
48.19, p < .001), with significantly more ASD probands with secondary psychological diagnoses. Psychological diagnoses included:
ADHD, learning disabilities, major depressive disorder, anxiety, OCD, and PTSD. Twenty-four participants were taking psychoactive
medications at the time of participation (7 ASD probands, 5 ASD siblings, 6 mothers of ASD probands, 1 father of an ASD proband, 2
TDCs, 2 control mothers, 1 control father). Groups significantly differed in the use of psychoactive medications (χ2 = 21.59, p =
.001), with greatest use of medication among ASD probands.
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Clinical Diagnosis and Assessment
Measures administered to all participants 1. See Table 3 for an overview of the tests
administered. The Trail Making Test A and B (adult version) and digit span (DS) forward and
backward were administered to assess levels of attention and processing speed. Intellectual
functioning was determined using the Wechsler Abbreviated Scale of Intelligence (WASI;
Wechsler, 1999).
Parent-report youth measures. Parents provided demographic information about their
children. The Social Communication Questionnaire (SCQ) was given to parents of TDCs and
ASD probands to either rule out ASD diagnosis or help confirm ASD diagnosis, respectively.
The SCQ is designed to measure communication and social functioning, with scores of 12 or
higher indicative of ASD (Corsello et al., 2007). Social functioning was evaluated in youth
using the parent-report version of the Social Responsiveness Scale, Second Edition (SRS-II), a
measure designed to assess subthreshold levels of social impairment across a continuum of social
functioning (Constantino et al., 2003), with scores 76 or above indicative of levels of social
impairment (Constantino, Zhant, Frazier, Abbacchi, & Law, 2010). To assess the broader autism
phenotype in siblings and all TDC youth, parents completed the youth version of the Autism
Spectrum Quotient (AQ; Baron-Cohen, Hoekstra, Knickmeyer, & Wheelwright, 2006), a
measure that assesses social and communication skills, imagination, attention to detail, and
1

We were unable to obtain any survey measures for one ASD proband, three ASD siblings, and
one mother of an ASD proband. Only the SRS-II was completed for one ASD proband and
another ASD proband had excessive missing responses on the SCQ. We initially administered
the first version of the SRS to all participants but were unable to obtain an updated SRS-II from
eight participants. We utilized the first version of the SRS to determine whether each participant
met cutoff criteria for participation but excluded them from all SRS-II analyses.
Neuropsychological tests were not administered to one father of an ASD proband, one control
father, one control mother, and one TDC sibling. DS scores were missing from two TDCs and
TMT A scores were missing from one ASD sibling due to timer malfunction. One father of an
ASD proband did not complete IQ testing.
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attention switching/tolerance of change. Scores of 30 or above indicate the presence of ASD
symptoms (Baron-Cohen et al., 2006). Parents of TDC and ASD youth completed the Screen for
Child Anxiety Related Disorders (SCARED), a measure of anxiety (Birmaher et al., 1997).
Table 3
Summary of Measures Administered
Domain
Broader Autism Phenotype
Autism Diagnosis

Emotional/Behavioral Functioning

Cognitive Functioning

Tests Administered

Participants Assessed

BAPQ

Parents

AQ

Parents, ASD siblings, TDC youth

ADOS-G

ASD probands

SCQ

All youth

SRS-II

All participants

SCARED

All youth

BDI-II

All parents

STAI

All parents

WASI

All participants

Digit Span

All Participants

TMT A & B

All Participants

Note. BAPQ = Broader Autism Phenotype Questionnaire, AQ = Autism Spectrum Quotient,
ADOS-G = Autism Diagnostic Observation Schedule-Generic, SCQ = Social Communication
Questionnaire, SRS = Social Responsiveness Scale, SCARED = Screen for Child Anxiety
Related Disorders, BDI = Beck Depression Inventory, STAI = State-Trait Anxiety Inventory,
WASI = Weschler Abbreviated Scales of Intelligence, TMT = Trail Making Test.
Adult measures. All parents provided self-reported demographic information. Parents
also reported their spouse’s behavior on the adult informant-report version of the SRS-II. To
assess the broader autism phenotype, all adults completed the Broader Autism Phenotype
Questionnaire (BAPQ; Hurley, Losh, Parlier, Reznick, & Piven, 2007), a questionnaire that
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measures aloof and rigid personality characteristics and pragmatic language problems. The
BAPQ is adequately sensitive and specific (>70% for all subscales) at identifying phenotypic
characteristics of ASD in adults with genetic connections to ASD (Hurley et al., 2007). All
parents also completed the adult version of the AQ (Baron-Cohen, Wheelright, Skinner, Martin,
& Clubley, 2001) with scores of 32 or above indicative of the presence of ASD symptoms
(Baron-Cohen et al., 2001). Previous studies of the AQ indicate that parents of ASD probands
score higher than parents of TDCs, suggesting this measure is a reliable indicator of ASD
characteristics (Wheelright, Auyeung, Allison, & Baron-Cohen, 2010). Finally, all parents
completed the Beck Depression Inventory-II (Beck, 1996), and State-Trait Anxiety Inventory
(Spielberger, Gorusch, Lushene, Vagg, & Jacobs, 1983).
Autism diagnosis. Autism diagnostic status was assessed in all youth participants to
either confirm or rule-out ASD. Mental health providers, psychiatrists, or physicians in the
community previously diagnosed all probands with ASD. Diagnosis was confirmed among
probands using the Diagnostic and Statistical Manual of Developmental Disorders-IV (DSM-IV)
criteria based on information from the Autism Diagnostic Observation Schedule-Generic
(ADOS-G; Lord et al., 2000), a measure designed to assess current functioning in the domains of
social interaction, communication, play, and creativity (Lord et al., 2000). The ADOS-G is a
well-established valid and reliable measure as indicated by excellent internal consistency, testretest reliability, and accurate differentiation between individuals with ASDs compared to nonspectrum individuals (Lord et al., 2000). The ADOS-G was administered by Mikle South or by
Ann Clawson who both received specific diagnostic training for ADOS administration and
scoring. Inclusion as an ASD proband required meeting ADOS total cut-off score for ASD of 7
and either a score above 12 on the Social Communication Questionnaire (SCQ) or a score of 76
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or above on the Social Responsiveness Scale, Second Edition (SRS-II). Siblings and TDC youth
scored below 76 on the SRS-II, suggesting they likely did not display severely elevated levels of
ASD symptoms suggestive of functional impairment (Kaiser et al., 2010) 2.
Experimental Task
All participants completed a modified Eriksen flanker task (Eriksen & Eriksen, 1974) to
elicit behavioral and error responses similar to a task successfully used to study performance
monitoring by our lab in previous studies of individuals with ASD (South et al., 2010).
Participants were presented with a five-letter array with the letters ‘H’ or ‘S’ (e.g., HHHHH,
SSSSS, HHSHH, SSHSS) and instructed to respond to the middle (target) letter as quickly and
accurately as possible with a right-hand middle or index finger button press. The task included
three blocks of 200 trials for 600 total trials; 50% of the trials were incongruent (e.g., HHSHH,
SSHSS) and 50% were congruent (e.g., SSSSS, HHHHH). Previous research suggests that this
task is developmentally appropriate for comparison in youth and adults, as both Ridderinkhof et
al. (1997) and Rueda et al. (2004) found that by 10 years of age children are less susceptible to
response competition and display conflict scores similar to adults.
Stimuli were presented in white against a black background on a 17-inch computer
monitor approximately 24 inches from the participant’s head. Response types (i.e., H or S target
letters) were counterbalanced across participants. Flanker stimuli were presented 100ms before
target stimuli, which remained on the screen for 600ms. The inter-trial interval varied randomly
between 800ms and 1200ms. Participants completed 24 practice trials while they were observed

2

One youth with ASD was missing both SRS-II and SCQ scores and three siblings were missing
SRS-II scores. ADOS-G scores were obtained from the ASD proband (total score of 21),
indicating that he clearly displayed symptoms of ASD above the diagnostic threshold. All of
these participants were retained in analyses in order to maintain statistical power.
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by an experimenter to ensure adequate understanding; the practice task was repeated until
participants achieved at least 70% accuracy.
EEG Recording and Reduction
Electroencephalogram was recorded using a 128-channel geodesic sensor net and
Electrical Geodesics, Inc. (EGI; Eugene, OR) amplifier system (20K nominal gain, bandpass =
.10-100Hz). Recordings from the 128 scalp sites were initially referenced to the vertex electrode
and digitized continuously at 250Hz with a 24-bit analog-to-digital converter. Following
manufacturer guidelines, impedances were maintained below 50kΩ. Data were average-rereferenced off-line and digitally low-pass filtered at 30Hz. Bad channels were identified as
channels with less than a .4 absolute correlation with neighboring channels. Bad channels were
also identified on a trial-by-trial basis if they had a difference of 100μv from the
minimum/maximum values for that trial or if they differed 30μv or more from neighboring
channels. Trials with more than 10% bad channels were removed from analyses, and a channel
marked bad on more than 20% of trials was considered globally bad. Eye blinks were removed
using independent component analysis and saccades were removed using principal components
analysis with promax rotation on EEGLAB (Delorme & Makeig, 2004) and the ERP PCA
Toolkit (Dien, 2010). Eye blink components in the current data were compared to two blink
templates; a manually generated template and a template automatically generated based on the
current data. Components that correlated at .9 with either template were removed from the data
(Dien, Michelson, & Franklin, 2010). For saccades, components that correlated at .8 with a
manually generated template were removed from the data. Movement artifact was identified for
removal on an individual trial basis using a temporal PCA. Activity with an amplitude
difference greater than 200μv was removed from analyses (Dien, 2010).
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Individual-subject ERP data were segmented according to participant response and
calculated separately for correct and incorrect trials. In order to ensure reliability of ERP and
behavioral analyses, participants with less than six error trials were excluded from analyses
(Olvet & Hajcak, 2009a). Epochs of interest spanned from 400ms pre-response to 800ms postresponse and were baseline adjusted from -400 to -200ms. Error-related negativity/correctresponse negativity (CRN) amplitudes were calculated as the average negative amplitude from
15ms pre- and 15ms post-peak using a window between 0-150ms. We chose to utilize this
adaptive mean procedure (i.e., averaging 15 ms around a peak) for the ERN/CRN, as this
procedure has been recommended to reduce bias in developmental populations where there is a
greater likelihood of variability in peak latency (Clayson, Baldwin, & Larson, 2013). Errorrelated negativity and correct-response negativity amplitudes were extracted as the average of
electrodes FCz, 7, 106, and Cz (see Figure 3). Pe amplitudes were extracted using a window
from 200-400ms and calculated as the mean amplitude across electrodes 54, 55, 78, 79, 61, and
Pz (see Figure 3). Windows and electrode locations were chosen based on examination of the
current data and previous studies suggesting that the ERN/Pe are fronto-centrally located
(Falkenstein et al., 2000; Gehring et al., 1993; Larson, South, Clayson, & Clawson, 2012). We
utilized an ROI-based approach for electrode selection, as research indicates that averaging
across multiple electrodes improves reliability of ERP measurement (Baldwin, Larson, &
Clayson, in press; Huffmeijer, Bakermans-Kranenburg, Alink, & van Ijzendoorn, 2014). To
capture the difference between error and correct trials and further isolate error-related activity,
we also calculated ΔERN and ΔPe scores by subtracting correct trial ERPs from error trial ERPs.
For all behavioral and electrophysiological data errors of omission were excluded from analyses
because there is no clear point at which errors are made to measure ERPs.
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Figure 3. Layout of the 128-channel geodesic sensor net. The solid line outlines the frontocentral electrodes averaged for ERN analyses. The dashed line outlines the more posterior
electrodes averaged for Pe analyses.

Statistical Analysis
Statistical analyses were completed with both SPSS 22 (IBMCorp., 2013) and STATA
13.1 (StataCorp, 2013) analysis software. All symptom measures (e.g., AQ, SRS, BAPQ),
behavioral data (i.e., RTs and error rates) and ERP data were examined for outliers by group
(ASD, control). Outliers were fenced to 2.5 interquartile ranges from the median. Response
time data were negatively skewed and not normally distributed as indicated by the Shapiro-Wilk
test of normality (Razali & Wah, 2011). Thus, RT data were log transformed. To ensure there
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were no group differences in signal-to-noise ratios, all ERP measures were initially analyzed
using one-way ANOVAs on background noise estimates, number of trials corrected for ocular
artifact, and number of trials retained for single subject averaging (Clayson et al., 2013). Nonsignificant differences between groups for trial number and noise analyses suggest similar noise
and/or trial counts.
Demographic and neuropsychological data. We initially compared ASD and control
groups to determine if there were any differences in demographic and neuropsychological data.
Descriptive statistics were computed for demographic characteristics (age, years of education).
One-way ANOVAs were conducted separately for parents and youth to examine demographic,
psychological (BDI, STAI, SCARED), and neuropsychological variables (WASI, TMT A and B,
DS). Significant ANOVAs were decomposed using the Tukey Honestly Significance test in
order to maintain alpha levels while completing multiple comparisons. Given that groups did not
have equivalent sample sizes, we utilized a harmonic mean procedure.
Unless otherwise noted, for all statistical analyses parent groups included mothers of
ASD probands, fathers of ASD probands, control mothers, and control fathers. Youth groups
included ASD probands, ASD siblings, TDC probands, and TDC siblings. TDC probands were
included in order to facilitate analysis by kinship status. One TDC from each control family was
randomly selected as the “proband” and one as the “sibling.”
Regression analyses. We utilized the following procedures for all regression analyses
unless otherwise specified below. To examine differences in dependent variables by group
(ASD/ASD relative, control) and kinship (mother, father, sibling, proband), we included group,
kinship, and a Group x Kinship interaction as independent variables. Previous research indicates
that including kinship and Group x Kinship interactions as regression terms is advantageous in
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determining familial aggregation of a trait, facilitating an examination of the unique affect of
kinship on the dependent variables of interest (Lee, Rebora, Valsecchi, Czene, & Reilly, 2013).
Participants were dummy coded separately by group (ASD/ASD relative, control) with ASD
participants and their relatives as the reference group, and by kinship status (mother, father,
sibling, proband) with either probands as the reference group or mothers as the reference group.
For all regression analyses, families were included as clusters in order to account for nonindependence of residuals due to shared genetic and environmental effects within families (Ari &
Güvenir, 2002). Clustering allowed us to account for possible correlations within families while
still examining differences between families. Robust standard errors were estimated using the
Huber-White sandwich estimator in STATA for clustered data in order to account for
nonindependence of observations due to family membership (Lee et al., 2013). The variance
inflation factor (VIF) was reported as a measure of multicollinearity (Kleinbaum, Kupper,
Muller, & Nizam, 2007).
Aim 1, hypothesis 1. To determine whether subthreshold symptoms of ASD differed
based on kinship status among unaffected relatives of ASD probands compared to control
families. Separate linear regressions were conducted with SRS-II, BAPQ, and AQ as dependent
variables. The independent variable of kinship differed based on the dependent variable, as all
measures were not administered to all participants due to age/diagnosis. For the SRS-II, which
was administered to all participants, the independent variable of kinship included mother, father,
sibling, and proband. For the AQ, which was only administered to control families and relatives
of ASD probands, kinship only included mother, father, and sibling. For the BAPQ, which was
only administered to parents, kinship included mothers and fathers only. We also included years
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of education as a predictor for BAPQ given the presence of significant group differences based
on educational attainment.
Aim 2, hypothesis 1. To test whether ASD probands displayed reduced-amplitude ERN,
Pe, and impaired behavioral modification relative to TDC youth. We conducted robust
ANOVAs on electrophysiological and behavioral data. Robust ANOVAs were utilized to reduce
potential assumption violations due to outliers, distribution non-normality, and homogeneous
error variance assumed in traditional ANOVAs (Keselman, 1998; Keselman, Wilcox, & Lix,
2003). Robust ANOVAs included winsorized covariances, bootstrapping, and use of the WelchJames statistic. For bootstrapping, the number of iterations was 50,000 and the seed for number
generation was 1000 (Dien, Franklin, & May, 2006; Dien et al., 2010). For all ANOVAs the
TDC youth were combined into one group, meaning they were not divided into separate groups
based on probands and siblings in order to replicate previous studies and examine group
differences independent of kinship (Henderson et al., 2006; South et al., 2010). For the ERN and
Pe, robust ANOVAs included Group (ASD proband, TDC youth) and Accuracy (error, correct).
For RTs and error rates, ANOVAs included Group (ASD proband, TDC youth) and Congruency
(congruent, incongruent).
Aim 2, hypotheses 2. To determine whether behavioral and ERP response differences
were evident to a greater degree in unaffected relatives of youth with ASD compared to control
families. Generally following the procedures employed by Bramon et al. (2004) in a family
study of the mismatch negativity in schizophrenia, linear regression was utilized to examine
group differences in ERP and behavioral measures. Regressions were conducted separately for
the following dependent variables: incongruent error rates, incongruent RTs, ΔERN, and ΔPe.
We chose to utilize difference scores for ERP measures in order to isolate error-related activity
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(i.e., subtracting out the activity that was common to correct and error responses) and reduce the
number of comparisons. In addition to the independent variables noted above, in order to
determine whether increased levels of ASD symptomology were associated with a greater degree
of electrophysiological and behavioral impairment, we also included SRS-II as an independent
variable in all regressions.
Aim 2, hypotheses 3. To examine whether increased levels of ASD symptomology would
be associated with a greater degree of electrophysiological and behavioral impairment. In order
to examine the relationship between ERP and behavioral measures and symptoms of ASD, we
conducted zero-order correlations between incongruent error rates, incongruent RTs, ΔERN,
ΔPe, SRS-II, BAPQ, and AQ. Further, past research suggests that internalizing symptoms, as
indicated by measures of anxiety symptomology, are related to enhanced ERN amplitudes
(Amodio, Master, Yee, & Taylor, 2008; Moser et al., 2013; Ruchsow et al., 2007; Weinberg,
Olvet, & Hajcak, 2010) and may play a role in explaining ERN generation in ASD (Henderson et
al., 2015). Thus, we also included SCARED scores for youth participants and STAI-State and
STAI-Trait scores for adults. Finally, Henderson et al. (2006) also observed significantly larger
ERN amplitudes among children with higher VIQ scores, so we included VIQ scores in our
correlations.
Results
Demographic Data
Youth. Demographic, neuropsychological, and symptom measures for youth are
displayed in Table 1. As noted above, group differences for measures of autism symptoms are
included in the regression analyses. ASD probands and siblings and TDC probands and siblings
did not significantly differ on age, F(3, 68) = 1.46, p = .23, or years of education, F(3, 62) =
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0.56, p = .64. However, youth significantly differed on measures of anxiety, F(3, 63) = 8.07, p <
.001. These group differences were primarily driven by ASD probands, who displayed
significantly higher levels of anxiety than other participants. Specifically, post-hoc testing
revealed significant mean differences between ASD probands and ASD siblings (M = 9.41, p =
.03), TDC probands (M = 13.21, p < .001), and TDC siblings (M = 13.23, p < .001). No mean
differences were significant between TDC siblings and ASD siblings (M = -3.81, p = .64), TDC
siblings and TDC probands (M = -0.02, p = 1.00), and TDC probands and ASD siblings (M = 3.80, p = .66). In sum, demographics were similar between groups with the exception of anxiety
where ASD probands displayed higher levels of anxiety relative to the other youth groups, but
TDC and ASD siblings did not differ.
Parents. Demographic, neuropsychological, and symptom measures for parents are
displayed in Table 2. Parents of children with ASD and parents of TDC children did not
significantly differ in age or on measures of anxiety and depressive symptoms (Fs < 2.11, ps >
.11). However, parent groups did significantly differ in years of education, F(3, 66) = 4.31, p =
.001. Group differences were driven by higher levels of educational attainment among control
fathers, as mean differences were significantly higher in control fathers than control mothers (M
= 2.78, p = .85) and significantly higher in control fathers than mothers of ASD probands (M =
2.25, p = .06). Mean differences were not significant between fathers of ASD probands and
control fathers (M = -2.08, p = .08), fathers of ASD probands and control mothers (M = 0.70, p =
.85) or mothers of ASD probands (M = 0.17, p = 1.0). Mothers of ASD probands did not display
mean differences in years of education relative to control mothers (M = 0.54, p = .92).
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Neuropsychological Data
Youth. Mean FSIQ scores were above average for siblings and TDC youth and slightly
above average for ASD probands (see Table 1), suggesting that all youth groups were generally
functioning at or above normative levels. All youth groups did not significantly differ on FSIQ,
VIQ, PIQ, DS, or TMT A and B (Fs < 2.13, ps > .11).
Parents. Analyses of FSIQ among mothers of ASD probands, fathers of ASD probands,
control fathers, and control mothers revealed significant group differences, F(3, 66) = 2.78, p =
.05, and approached significance for VIQ, F(3, 66) = 2.58, p = .06. Group differences were not
present for PIQ scores, F(3, 66) = 2.36, p = .08. Control fathers displayed significantly higher
FSIQ (M = 7.91, p = .04) and VIQ scores (M = 8.57, p = .04) than mothers of ASD probands.
No other mean differences were significant between groups for FSIQ or VIQ (Ms > 0.17, ps <
1.0. Parents did not significantly differ on TMT A and B t-scores, Fs < 1.76, ps > .17. Finally,
groups differed on DS standard score, F(3, 64) = 4.85, p = .004, with significantly lower scores
in control mothers relative to control fathers (M = -2.44, p = .05) and mothers of ASD probands
relative to control fathers (M = -3.06, p = .01). Fathers of ASD probands did not display
significant mean differences from control fathers (M = .94, p = .74), control mothers (M = 1.49,
p = .39), or mothers of ASD probands (M = 2.11, p = .11). Taken together, significant
differences were observed between control fathers and mothers of ASD probands/control
mothers on FSIQ, VIQ and DS. These differences may be attributable to higher levels of
education attainment in control fathers relative to control mothers and mothers of ASD probands
as noted above.
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ERP Data
Youth and parent groups did not significantly differ on background noise estimates, number of trials retained for analysis, or
number of trials corrected for ocular artifact for correct and error trials (youth: Fs < 2.15, p > .10, adults: Fs < 2.65, p = .06; see Tables
Table 4
ERP and Behavioral Summary Data for Youth

ASD Probands
Measure

M

SD

Range

ERN

-1.08

1.89

CRN

0.43

Pe
Pc

ASD Siblings
M

SD

Range

-3.46-2.21

-0.81

1.73

1.56

-2.04-2.87

1.35

3.08

1.60

0.98-6.48

0.05

1.77

-3.35-2.79

RT Incongruent

445.16

33.65

RT Congruent

419.28

32.22

Error Incongruent

.36

.15

Error Congruent

.19

.11

Correct Trials
Error Trials

Control Youth
M

SD

Range

-3.42-2.02

-1.09

2.52

-6.80-3.65

1.79

-1.73-3.97

0.89

2.00

-2.90-6.24

4.34

2.78

-0.74-10.09

5.09

3.32

-0.67-12.85

0.04

2.36

-4.20-3.88

0.52

2.01

-3.95-4.82

372.04-509.18

454.70

32.78

396.33-519.81

460.06

41.06

356.92-524.47

356.79-464.31

427.90

34.22

382.68-493.44

422.07

40.84

301.14-493.37

.15-.73

.34

.11

.15-.56

.31

.14

.06-.61

.07-.41

.20

.11

.03-.46

.15

.11

.02-.36

321.31

158.65

165-771

306.07

94.85

177-511

315.39

177.66

95-522

78.50

50.21

18-162

65.00

24.41

24-116

56.78

31.07

11-135

Note. ERN = error-related negativity, CRN = correct-related negativity, Pc = post-correct positivity, Pe = post-error positivity, RT =
response time.
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4 and 5). All participants included in ERP analyses had at least six error trials for averaging, suggesting an adequate number of trials
were retained for reliable analyses (Olvet & Hajcak, 2009b). Means and standard deviations for all ERP and behavioral data are
presented in Table 4 and Table 5.
Table 5
ERP and Behavioral Summary Data for Adults
ASD Fathers
SD

ASD Mothers
SD

M

ERN

-1.89

3.24

-9.93-2.20

-2.32

2.93

-9.03-1.83

-1.99

2.32

-6.89-1.59

-1.55

2.25

-7.56-1.56

CRN

1.42

0.96

0.11-2.93

0.51

1.90

-4.82-3.84

1.42

1.50

-2.45-4.18

0.62

1.86

-2.27-4.48

Pe

3.17

2.54

0.18-9.04

2.66

2.13

0.72-7.86

2.66

2.46

-1.32-7.84

2.89

2.62

-1.37-10.99

Pc

1.02

1.31

-0.87-3.27

0.89

1.48

-0.82-5.26

0.87

1.52

-1.12-4.50

0.50

1.33

-2.22-2.88

Range

M

SD

Control Mothers

Measure

Range

M

Control Fathers
Range

M

SD

Range

Incongruent RT

483.02 45.06 409.28-584.69

467.58 39.22 392.94-561.54

480.62 29.61

422.88-527.39

476.09 33.34 412.38-540.44

Congruent RT

432.67 47.01 346.59-520.29

415.26 38.27 349.86-496.08

422.92 29.06

372.24-476.77

424.85 36.28 330.52-487.51

Incongruent Error

.25

.14

.05-.57

.20

.12

.50-.39

.20

.11

.08-.51

.19

.10

.04-.33

Congruent Error

.08

.07

.00-.23

.06

.04

.01-.16

.06

.05

.01-.25

.06

.05

.00-.22

378.29 84.60

214-504

452.06 51.17

342-542

441.21 69.91

287-541

428.11 69.91

287-541

48.29 26.94

7-117

45.41 35.43

10-146

37.21 16.57

10-64

40.28 23.76

7-77

Correct Trials
Error Trials

Note. ERN = error-related negativity, CRN = correct-related negativity, Pc = post-correct positivity, Pe = post-error positivity, RT =
response time.
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Aim 1, Hypothesis 1
To determine whether subthreshold symptoms of ASD differed based on kinship status
among unaffected relatives of ASD probands compared to control families.
SRS-II. Findings of the regression model are summarized in Table 6. Variance inflation
factor scores indicated that no independent variables were multicollinear for the SRS-II. The
overall model was significant, F(7, 36) = 63.45, p < .001, and accounted for 74% of the variance
in SRS-II scores. Group status significantly predicted SRS-II scores, with significantly higher
SRS-II scores among ASD families compared to control families. Kinship was also a significant
predictor. Mothers, fathers, and siblings all displayed significantly lower SRS-II scores than
probands. Importantly, Group x Kinship interactions were significant. ASD mothers displayed
significantly higher SRS-II scores than control mothers, ASD fathers displayed significantly
higher scores than control fathers, and ASD siblings displayed significantly higher scores than
TDC siblings. Thus, results followed the expected pattern, with higher levels of ASD symptoms
among ASD probands and unaffected relatives of ASD probands relative to control families.
AQ. See Table 6 for regression findings. No independent variables were multicollinear
for the AQ. The overall model was significant, F(5, 38) = 2.47, p = .05, and accounted for 15%
of the variance. However, no individual predictors were significant, including group and kinship
for fathers and siblings. The interaction between kinship and group was also not significant for
fathers or siblings.
BAPQ. See Table 6 for regression findings. No independent variables were
multicollinear. The overall model was not significant, F(4, 37) = 1.39, p = .26, and accounted
for 6% of the variance. No predictors were significant, including group and kinship. The
interaction between kinship and group was also not significant.
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Table 6
Regression Model for Symptom Measures
B

Robust SE

t-value

p-value

VIF

-34.6

2.33

-14.86

<.01

3.76

Mothers

-33.3

2.37

-14.05

<.01

3.04

Fathers

-29.56

2.59

-11.41

<.01

3.22

Siblings

-29.23

4.74

-6.17

<.01

3.51

Control Mothers

34.42

2.84

12.14

<.01

3.46

Control Fathers

27.87

2.91

9.56

<.01

3.80

Control Siblings

33.03

4.93

6.71

<.01

4.25

1.65

2.08

0.80

.43

2.91

Fathers

3.89

2.73

1.42

.16

2.80

Siblings

-2.22

2.44

-0.91

.37

3.04

Control Fathers

-.26

3.33

-0.08

.94

3.56

Control Siblings

.22

2.87

0.08

.94

3.89

-0.05

0.03

-1.96

.06

1.20

0.04

0.21

0.17

.86

2.01

0.22

0.28

0.78

.44

2.12

0.04

0.33

0.11

.92

3.40

Variables
DV: SRS-II

R2

p-value

.74

<.01

Group
Kinship

Group x Kinship

DV: AQ

.15

.05

Group
Kinship

Group x Kinship

DV: BAPQ
Years of Education
Group

.06

.26

Kinship
Fathers
Group x Kinship
Control Fathers

Note. SE = standard error, VIF = variance inflation factor, SRS = Social Responsiveness Scale,
AQ = Autism Spectrum Quotient, BAPQ = Broader Autism Phenotype Questionnaire.
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In summary, we observed significant group differences in ASD symptoms as measured
by the SRS-II that followed the predicted direction of significantly greater symptoms in ASD
probands and relatives compared to control families. Contrary to predictions, groups did not
differ on measures of the broader autism phenotype as measured by the AQ and BAPQ.
Aim 2, Hypothesis 1
To test whether ASD probands displayed reduced-amplitude ERN, Pe, and impaired
behavioral modification relative to TDC youth.
ERN. The Group x Accuracy robust ANOVA examining ERN amplitudes among ASD
probands and all TDC youth revealed a significant main effect of accuracy, with significantly
more negative amplitudes on error trials relative to correct trials, TWJt/c(1.0, 28.5) = 61.77, p <
.001. The main effect of group was not significant, TWJt/c(1.0, 26.2) = 0.32, p = .58.
Importantly, the Accuracy x Group interaction was not significant, TWJt/c(1.0, 28.5) = 0.87, p =
.36, suggesting that no significant group differences were observed for the ERN.
Pe. The main effect of accuracy was significant, with more positive Pe amplitudes on
error trials than correct trials, TWJt/c(1.0, 34.0) = 69.38, p < .001. The main effect of group was
not significant, TWJt/c(1.0, 24.1) = 1.15, p = .29. The Group x Accuracy interaction was also not
significant, TWJt/c(1.0, 34.0) = 1.27, p = .26. Thus, group differences were not observed for Pe
amplitude.
Behavioral data. For error rates, robust ANOVAs revealed a significant main effect of
congruency, TWJt/c(1.0, 36.1) = 153.21, p< .001. The main effect of group and Group x
Congruency interaction were not significant, TWJt/c(1.0, 25.9) = 0.23, p = .64; TWJt/c(1.0, 36.1) =
0.80, p = .38, respectively. For RTs, the main effect of congruency was significant, TWJt/c(1.0,
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24.9) = 81.86, p < .001. The main effect of group and Group x Congruency interaction were not
significant, TWJt/c(1.0, 27.0) = 0.19, p = .67; TWJt/c(1.0, 24.9) = 0.14, p = .71, respectively.
In summary, we did not replicate previous findings of significant group differences for
ERN amplitudes (Sokhadze et al., 2010; South et al., 2010; Vlamings et al., 2008) and we did not
observe group differences for behavioral measures or amplitude of the Pe ERP.
Aim 2, Hypotheses 2
To determine whether behavioral and ERP response differences were evident to a greater
degree in unaffected relatives of youth with ASD compared to control families.
ΔERN. See Figures 4-7 for waveforms and scalp maps according to group. Findings of
the regression models for all ERPs are summarized in Table 7. Although we initially planned to
include SRS-II as a predictor in our regressions, analyses revealed that the SRS-II was highly
related to group, leading to significant multicollinearity in our regressions (VIFs for group
ranging from 9.91-10.03). Thus, we chose to exclude SRS-II as a predictor for ERP and
behavioral regressions. After removing the SRS-II, VIF scores for ΔERN, ΔPe, RTs, and error
rates suggested that no independent variables were multicollinear in all analyses. The overall
ΔERN model was not significant, F(7, 37) = 1.21, p = .32, and accounted for 6% of the variance
in ΔERN scores. Group was also not a significant predictor. Kinship was not a significant
predictor among mothers, fathers, or siblings relative to probands, and no interactions between
kinship and group were significant.
ΔPe. See Figures 4 and 8-10 for waveforms and scalp maps according to group. The
model for ΔPe amplitudes was significant, F(7, 37) = 9.38, p < .001, and accounted for 23% of
the variance in ΔPe. The effect of group approached significance. The effect of kinship was
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significant for mothers and fathers but not siblings. Interactions between group and kinship were
only significant for fathers.

Figure 4. ΔERN and ΔPe amplitudes by youth and adult groups. ΔERN amplitudes were
averaged over electrodes FCz, 7, 106, Cz. ΔPe amplitudes were averaged over electrodes 54, 55,
78, 79, 61.
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Figure 5. ΔERN amplitude topographical maps by youth and adult groups. Scalp maps
represent the average from 0-150ms.

Figure 6. ERN and CRN amplitudes by youth group. Averaged over electrodes FCz, 7, 106, Cz.
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Figure 7. ERN and CRN amplitudes by adult group. Averaged over electrodes FCz, 7, 106, Cz.

Figure 8. ΔPe amplitude topographical maps by youth and adult groups. Scalp maps represent
the average from 200-400ms.
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Figure 9. Pe and Pc amplitudes by youth group. Averaged over electrodes 54, 55, 78, 79, 61.

Figure 10. Pe and Pc amplitudes by adult group. Averaged over electrodes 54, 55, 78, 79, 61.
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Table 7
Regression Model for ERP Measures

Variables
DV: ΔERN

R2

p-value

.06

.322

B

Robust SE

t-value

p-value

VIF

-0.38

0.31

-1.22

.229

4.07

Mothers

-0.40

0.30

-1.33

.190

3.15

Fathers

-0.63

0.42

-1.50

.142

3.34

Siblings

-0.24

0.23

-1.07

.293

3.29

Control Mothers

0.63

0.51

1.23

.227

3.68

Control Fathers

0.17

0.52

.32

.750

4.01

Control Siblings

0.46

0.37

1.26

.214

3.93

1.01

0.52

1.93

.061

4.07

Mothers

-0.92

0.28

-3.25

.002

3.15

Fathers

-0.62

0.30

-2.08

.045

3.34

Siblings

0.74

0.44

1.67

.103

3.29

Control Mothers

-0.64

0.51

-1.18

.245

3.68

Control Fathers

-1.14

0.57

-2.00

.052

4.01

Control Siblings

-0.64

0.67

-0.95

.349

3.93

Group
Kinship

Group x Kinship

DV: ΔPe

.23

Group

.001

Kinship

Group x Kinship

Note. SE = standard error, ERN = error-related negativity, Pe = post-error positivity, VIF =
variance inflation factor.
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Behavioral data. See Figure 11 for bar graphs depicting error rates and RTs by group.
Regression findings are summarized in Table 8. The model for error rates was significant, F(7,
37) = 9.47, p < .001, and accounted for 21% of the variance in incongruent trial error rates.
Group was not a significant predictor. However, kinship was significant for mothers and fathers
but not siblings. Finally, no interactions between group and kinship were significant. The model
for RTs was significant, F(7, 38) = 2.66, p = .02, accounting for 11% of the variance in
incongruent RTs. Group was not a significant predictor and the Group x Kinship interaction was
not significant. However, kinship was significant for mothers and fathers, but not siblings.

Figure 11. Behavioral data as a function of group and trial type. Error bars represent the
standard error.
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Table 8
Regression Model for Behavioral Measures
Variables

R2

p-value

B

Robust SE

DV: Incongruent Errors

.21

<.01

p-value

VIF

-0.045

.05

-0.91

.37

3.93

Mothers

-0.156

.03

-5.28

<.01

2.99

Fathers

-0.115

.04

-2.76

.01

3.11

Siblings

-0.021

.04

-0.52

.61

3.22

Control Mothers

0.031

.05

0.61

.54

3.49

Control Fathers

-0.002

.05

-0.06

.96

3.72

Control Siblings

0.007

.06

0.11

.91

3.91

0.008

0.01

0.55

.58

3.93

Mothers

0.211

0.01

1.99

.05

2.99

Fathers

0.035

0.01

2.62

.01

3.11

Siblings

0.009

0.01

0.84

.41

3.22

Control Mothers

0.001

0.02

0.05

.96

3.49

Control Fathers

-0.009

0.02

-0.50

.62

3.72

Control Siblings

0.002

0.02

0.14

.89

3.91

Group

t-value

Kinship

Group x Kinship

DV: Incongruent RTs
Group

.11

.02

Kinship

Group x Kinship

Note. SE = standard error, RT = response time, VIF = variance inflation factor.
Aim 2, Hypotheses 3
To examine whether increased levels of ASD symptomology would be associated with a
greater degree of electrophysiological and behavioral impairment.
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Pearson’s correlations are presented in Table 9. Incongruent RTs and incongruent error
rates were not significantly associated with any variables except SRS-II scores, with higher SRSII scores predicting poorer behavioral performance (lower RTs, higher error rates). Autism
symptoms were not significantly related to ΔERN amplitudes, but lower AQ and BAPQ scores
were significantly related to enhanced ΔPe amplitudes. Contrary to expectations, anxiety was
not significantly related to ΔERN or ΔPe amplitudes among youth. Among adults, higher state
anxiety was associated with enhanced ΔERN amplitudes and lower levels of trait anxiety were
related to more positive ΔPe amplitudes.
Taken together, regressions examining group differences in ERP and behavioral
measures of performance monitoring partially followed predictions. No differences were
observed in ΔERN amplitude. ΔPe amplitude differed between ASD and control groups;
mothers and fathers differed from probands. For behavioral data, mothers and fathers displayed
faster RTs and less error rates than probands. Overall, individuals with higher levels of ASD
symptoms responded slower and made more errors, and higher levels of the broader autism
phenotype were significantly related to reduced ΔPe amplitudes. Higher state anxiety predicted
enhanced ΔERN and higher trait anxiety predicted enhanced ΔPe amplitudes among adults.
Supplementary Analyses
It is possible that including group as a predictor in regressions limited our ability to
understand the role of ASD symptomology and ERP generation, as limiting analyses to current
diagnostic definitions may reduce our ability to identify the influence of dimensional ASD
symptoms on ERP amplitudes (Miller & Rockstroh, 2013). Thus, we conducted regressions on
ΔERN and ΔPe amplitudes as dependent variables without group as a predictor. Independent
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Table 9
Pearson’s Correlations for ERPs, Behavioral, and Psychological Measures
ΔERN

ΔPe

Incongruent RTs

Incongruent Errors

SRS-II

.070

-.081

-.198*

.288**

AQ

.102

-.311**

.011

.002

BAPQ

.104

-.341**

-.002

.111

SCARED

-.003

-.273*

-.085

.221

STAI-State

.293*

-.204

.150

.202

STAI-Trait

.196

-.330**

-.018

-.012

VIQ

.015

-.001

.063

-.155

Note. ERN = error-related negativity, Pe = post-error positivity, RT = response time, SRS =
Social Responsiveness Scale, AQ = Autism Spectrum Quotient, BAPQ = Broader Autism
Phenotype Questionnaire, SCARED = Screen for Child Anxiety Related Disorders, STAI =
State-Trait Anxiety Inventory, VIQ = verbal intelligence quotient.
* p < .05. ** p < .01.
variables in regressions included SRS-II scores and kinship. As in previous analyses, we
estimated robust standard errors and included clustering by family.
See Table 10 for regression results. No predictors were multicollinear for ΔERN or ΔPe
analyses. The model for ΔERN amplitudes was not significant, F(4, 36) = 1.73, p = .17, and
explained 6% of the variance. Kinship and SRS-II were not significant predictors. The model
for ΔPe was significant, F(4, 36) = 11.50, p < .01, and explained 24% of the variance. In
addition, SRS-II was a significant predictor, with larger SRS-II scores associated with decreased
ΔPe amplitudes. Kinship was a significant predictor for mothers and fathers but not siblings.
Thus, analyses without group as a predictor remained consistent with ΔERN analyses but
revealed a significant relationship between symptoms of ASD and ΔPe amplitudes.
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Table 10
Regression Model for ERP Measures Without Group as a Predictor
Variables

R2

p-value

B

Robust SE

t-value

p-value

VIF

DV: ΔERN

.06

.165
0.006

0.01

0.73

.47

1.32

Mothers

-0.004

0.32

-0.01

.99

1.83

Fathers

-0.524

0.29

-1.81

.08

1.83

Siblings

0.055

0.22

0.25

.81

1.69

-0.028

0.01

-2.08

.05

1.32

Mothers

-1.643

0.40

-4.12

<.001

1.83

Fathers

-1.669

0.43

-3.90

<.001

1.83

Siblings

0.151

0.42

0.36

.72

1.69

SRS-II
Kinship

DV: ΔPe

.01

<.001

SRS-II
Kinship

Note. SE = standard error, ERN = error-related negativity, Pe = post-error positivity, VIF =
variance inflation factor.
Discussion
Due to the substantial heterogeneity in symptom presentation and complex genetic
profile, the use of endophenotypes is particularly important in ASD research. Endophenotypes
may elucidate mechanisms that mediate genes and symptoms and thereby represent unique
etiological paths to ASD. Thus, we sought to identify whether the ERN and Pe qualify as
electrophysiological endophenotypes of ASD by comparing ERP and behavioral (error rates,
RTs) data among ASD probands and their families relative to control families. Our results do no
provide sufficient evidence to support the ERN as an endophenotype of ASD, as we did not
observe expected group differences in ERN amplitude between ASD youth and control youth.
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Additionally, group and kinship did not predict ΔERN amplitudes within family-based ΔERN
analyses. Our results also confirm that the Pe is not an endophenotype of ASD, as we did not
observe significant group differences between ASD probands and TDCs but did see group
differences among fathers of ASD probands relative to control fathers. The implications of these
findings are discussed in relation to ASD specifically and the ERN/Pe as endophenotypes of
pathology more broadly.
The ERN: Neural Endophenotype or Biomarker?
In contrast to our predictions and previous research (Sokhadze et al., 2010; Sokhadze et
al., 2012; South et al., 2010; Vlamings et al., 2008), we did not observe significant group
differences in ERN amplitude when comparing ASD probands to TDC youth. These findings
suggest that the ERN does not meet the first criteria as an endophenotype of ASD, as ERN
amplitude differences were not associated with ASD and thus may not reflect underlying deficits
in cognitive functioning and neural development.
The current finding of no group differences in ERN amplitude adds to an overall mixed
literature on ERN amplitudes and error processing in ASD. While the preponderance of studies
reveal attenuated ERN amplitudes in ASD youth (Sokhadze et al., 2010; Sokhadze et al., 2012;
South et al., 2010; Vlamings et al., 2008) and adults (Santesso et al., 2011) relative to TDCs, two
studies among youth with ASD reveal a lack of group differences in ERN amplitudes relative to
TDC children (Henderson et al., 2015) and children with ADHD (Groen et al., 2008). Greateramplitude ERNs were observed in one study, but only when comparing ASD youth who had the
highest VIQ scores to TDCs (Henderson 2006). Thus, while several studies point to ERN
amplitude differences in ASD relative to controls, this pattern of results has not been replicated
in all samples.
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Also, within our sample, heightened levels of ASD symptoms as measured by the SRS-II
were not significantly correlated with ERN amplitudes in ASD, further bringing into question the
relationship between ERN amplitudes and the symptomatic behaviors of individuals with ASD.
The relationship between ASD symptom measures and deficits in error processing has not been
consistently observed in the literature. Indeed, multiple studies report no significant correlations
between symptom measures and ERN amplitudes or fractional anisotropy (FA) within the ACC
(Barnea-Goraly et al., 2010; Groen et al., 2008; Noriuchi et al., 2010; South et al., 2010;
Vlamings et al., 2008). Other studies report that higher levels of social impairment and/or
repetitive behaviors are related to reduced ERN amplitudes and reduced FA in the ACC
(Santesso et al., 2011; Thakkar et al., 2008) or, alternatively, that higher parent-reported
symptoms are associated with enhanced ERN amplitudes (Henderson et al., 2015). These
differences may reflect heterogeneity in ASD diagnosis and symptom presentation; all studies
included high functioning participants that may have presented with varying levels of severity of
social, communication, and restricted/repetitive behavior deficits. It may be that overall
symptom levels are less influential on ERN amplitudes than the specific nature of symptoms
(e.g., social or communication vs. restricted and repetitive behavior) or pattern of symptom
presentation (e.g., degree of social deficits relative to deficits in stereotyped behaviors).
In order to test whether ERN amplitude differences were present in relatives of ASD
probands, we examined the ΔERN in families of ASD probands relative to controls. Even with
the use of methods to specifically differentiate the effects of kinship and shared familial genetics,
group and kinship did not significantly predict ΔERN amplitude. These results indicate that the
ERN does not relate to kinship status in ASD and thus does not meet all criteria necessary to
qualify as a candidate endophenotype of ASD. In addition, the lack of differences in ASD
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probands relative to TDCs suggest that the ERN also does not qualify as a diagnostic biomarker
of ASD, as it appears that altered ERN amplitudes are neither specific indicators of disease
diagnosis nor genetic liability for ASD (Ritsner & Gottesman, 2009).
The Pe: Marker of Autism Symptoms?
In-line with our hypotheses, we observed no differences in Pe amplitude between ASD
probands and TDCs. A lack of group differences in Pe amplitude is consistent with the
preponderance of previous studies in individuals with ASD compared to controls (Groen et al.,
2008; Santesso et al., 2011; Sokhadze et al., 2010; South et al., 2010) and in studies comparing
individuals with other forms of psychopathology to controls (Chiu & Deldin, 2007; Endrass et
al., 2010; Ruchsow et al., 2005). Similar Pe amplitudes among ASD probands and TDCs
suggest that youth with ASD do not display differences in neural indices of error awareness used
to signal and initiate subsequent behavior change (Hajcak et al., 2004; Nieuwenhuis et al., 2001;
Steinhauser & Yeung, 2010). Further, a lack of group differences suggests that the Pe is not
consistently associated with diagnosis of ASD and thus does not qualify as an endophenotype or
biomarker of the disorder (Ritsner & Gottesman, 2009).
Contrary to predictions, group and kinship status were significant predictors of ΔPe
amplitude. Group x Kinship interactions were only significant for fathers, with significantly
more positive ΔPe amplitudes in control fathers relative to fathers of ASD probands, pointing to
reduced error awareness. Some evidence suggests that fathers of ASD probands may display
overall heightened levels of the broader autism phenotype (De la Marche et al., 2012) as well as
executive functioning deficits such as planning and attentional flexibility (Hughes, Leboyer, &
Bouvard, 1997) or set-shifting (Wong et al., 2006). Thus, fathers of ASD probands may display
a reduced ability to flexibly attend to and monitor their behavior, resulting in altered neural
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indices of error awareness. However, because this pattern was not observed in ASD probands,
these findings again suggest that the Pe is likely not an endophenotype or biomarker of ASD but
may point to underlying neural and/or cognitive abnormalities in fathers of ASD probands
representative of an overall genetic risk toward symptoms of ASD. In other words, the Pe may
reflect some degree of clinical symptomology but is not directly linked to clinical manifestations
of ASD and is thus not reliably tied to ASD diagnosis (Ritsner & Gottesman, 2009).
Mothers and fathers also displayed significantly larger ΔPe amplitudes than youth,
possibly due to more mature prefrontal neural development and enhanced neural efficiency
(Segalowitz & Dywan, 2009). This pattern of results has not been consistently observed in
studies of Pe amplitudes across development (Ladouceur, Dahl, & Carter, 2007; Santesso,
Segalowitz, & Schmidt, 2006; Wiersema, van der Meere, & Roeyers, 2007). However, all
previous studies included adults who were younger than adults in the current sample (typically
within ages 20-30) and may thus not capture developmental contrasts between youth and older
adults.
Implications for ASD
Taken together, our findings suggest that the ERN and Pe do not qualify as
endophenotypes of ASD. The ERN was not significantly different between ASD probands and
TDC youth, suggesting it does not meet the first criteria as an endophenotype. Likewise, no
group differences were observed in relatives of ASD probands compared to control families,
suggesting that the ERN also does not meet the fifth criteria as an endophenotype. Based on our
correlational analyses and evidence of a relationship between ASD symptoms and ERN
amplitudes in past research, it is yet unclear whether ERN amplitude differences are directly
related to symptoms of ASD (e.g., traits) or whether they are associated with state-related
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processes not specific to ASD (e.g., internalizing symptoms, broader cognitive dysfunction,
response to treatment; Gould & Gottesman, 2006). Given the variability of previous findings
and lack of group differences in the current study it is likely that these state- or trait-related
differences play a role in ERP generation and may explain significant group differences observed
in some but not all studies of the ERN in ASD.
Likewise, the Pe does not appear to qualify as an endophenotype of ASD. We did not
observe any group differences in Pe amplitude between ASD probands and TDCs, suggesting
that the Pe is not reliably associated with ASD diagnosis. Interestingly, kinship and group did
predict ΔPe amplitudes among fathers of ASD probands relative to control fathers and ASD
symptoms were significantly correlated with ΔPe amplitudes. The relationship between
heightened levels of ASD symptoms and reduced ΔPe amplitudes suggests that the Pe may
reflect underlying traits of ASD such that the presence of subthreshold social, communication,
and repetitive/restricted behaviors may reduce overall error awareness. However, because
changes in Pe amplitude were not associated with clinically significant manifestations of ASD,
the Pe is not a reliable diagnostic indicator.
One possible confound to our ability to identify the relationship between ASD symptoms
and ERP amplitudes may have been our reliance on group as a predictor in all regressions (Miller
& Rockstroh, 2013; Volkmar & McPartland, 2014). Groups were defined based on DSM-IV
diagnostic criteria for ASD. Using DSM-based diagnostic distinctions permitted examination of
the differences between ASD probands/relatives and controls but may have led us to rely too
heavily on categorical distinctions between normal functioning and clinical diagnosis. In a
discussion about the limitations of using current categorical diagnostic distinctions in
endophenotype research, Gould and Gottesman (2006) suggested that:
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DSM approaches provide a partially validated mechanism whereby physicians can
provide reliable diagnoses, communicate amongst themselves and report their findings to
insurance providers. However, disease heterogeneity implicit in the current classification
schema, and the imprecise quantification of the behaviors being described, makes it
difficult to even partially deconstruct such ‘diseases’ within model organisms. (p. 113)
Thus, although the use of DSM categorical distinctions has substantial clinical utility, it may
limit research aimed at understanding the underlying etiological mechanisms of disorders.
The limitation of utilizing DSM diagnostic criteria is particularly pertinent in ASD
research due to the high diagnostic heterogeneity, diversity of symptom presentation, and
variability of symptom severity (Happé et al., 2006). There has been considerable debate
amongst clinicians and researchers regarding diagnosis of ASD, particularly amongst individuals
with ASD who are higher functioning and thus similar to those included in the current project
and past research on the ERN in ASD (Lord & Bishop, 2015; Lord & Jones, 2012; Volkmar &
McPartland, 2014; Volkmar & Reichow, 2013). Also, current diagnostic criteria for ASD do not
include cognitive deficits (e.g., deficits in executive functioning) that may be especially relevant
in identifying whether the ERN is an endophenotype of ASD (Leung, Vogan, Powell,
Anagnostou, & Taylor, 2015; Miller & Rockstroh, 2013). Thus, although these ASD diagnostic
distinctions are based on research and currently utilized by clinicians, relying on current
definitions of ASD may have limited our ability to deconstruct the heterogeneity of ASD and
identify neural deficits that underlie symptoms of ASD regardless of diagnostic status.
Due to the heterogeneity of ASD diagnosis and limitations of current ASD diagnostic
criteria, we conducted additional supplementary analyses in which we removed group as a
predictor in regressions and only examined the relationship between dimensional measures of
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ASD symptoms (SRS-II scores), kinship, and ΔERN amplitudes. Again, SRS-II scores and
kinship were not significant predictors of ΔERN amplitudes, suggesting that even when
removing group status, ASD symptoms did not predict ΔERN amplitudes. These findings
reinforce that the ERN is not an endophenotype of ASD, as ERN amplitudes do not appear to be
related to dimensional aspects of ASD symptoms.
Interestingly, analyses on ΔPe amplitudes without group as a predictor did reveal that
ASD symptoms and kinship predicted ΔPe amplitudes, with higher SRS-II scores related to
significantly smaller ΔPe amplitudes. Correlations with ΔPe amplitude similarly indicated a
negative relationship between measures of the broader autism phenotype (AQ, BAPQ), with
higher scores associated with significantly reduced ΔPe amplitudes. The relationship between Pe
amplitude and the broader autism phenotype suggests that regardless of diagnosis, the social
deficits and repetitive, restricted behaviors characteristic of ASD are associated with
electrophysiological indicators of reduced error awareness. Reduced error awareness during
performance monitoring may contribute to poor behavioral flexibility and modification, resulting
in impaired social and emotional reciprocity and increased behavioral inflexibility.
Alternatively, anxiety may play a role in our results, as reduced ΔPe amplitudes were also
significantly associated with increased levels of trait anxiety in both adults and youth.
Individuals with heightened levels of ASD symptoms may be more aware of their subthreshold
social or behavioral deficits and feel increased concern about others’ evaluations, leading to
heightened levels of anxiety. Elevated levels of anxiety may tax attentional systems, reducing
overall error awareness (Eysenck, Derakshan, Santos, & Calvo, 2007). Thus, it may be that the
specific combination of heightened levels of ASD symptoms and elevated trait anxiety reduce
error awareness.
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Future Directions: The ERN as an Endophenotype
The findings of the current study have implications for a larger discussion of the utility of
the ERN and Pe as endophenotypes of psychopathology. As outlined previously, studies of the
Pe are inconsistent and generally suggest that the Pe does not qualify as a biomarker or
endophenotype of psychopathology. Thus, the following discussion will focus primarily on the
ERN.
There is growing dialogue about the utility of the ERN as an endophenotype (Manoach &
Agam, 2013; Moser et al., 2013; Olvet & Hajcak, 2008; Proudfit et al., 2013). Most research on
the ERN to date has explored the first criteria as an endophenotype, or whether the ERN is
associated with particular diagnoses. However, despite extensive research on the relationship
between the ERN and various state- and trait-related conditions (Clayson, Clawson, & Larson,
2012; Moser, Hajcak, & Simons, 2005; Olvet & Hajcak, 2012; Pailing & Segalowitz, 2004),
there is considerable within-subject and between-subject variability, bringing into question the
nature of the relationship between the ERN and psychopathology. The current study adds to a
mixed literature in which some, but not all psychological conditions are associated with changes
in ERN amplitude (e.g., Chiu & Deldin, 2007; Endrass et al., 2008; Groen et al., 2008; Hajcak et
al., 2003; Henderson et al., 2015; Ruchsow et al., 2006; South et al., 2010). Important questions
must be addressed in order to determine whether the ERN is best characterized as an
endophenotype or biomarker, including how particular symptoms are related to increases or
decreases in ERN amplitudes and to what degree environmental factors mediate the relationship
between ERN amplitude and symptom presentation (Proudfit et al., 2013).
Despite claims that the ERN does in fact qualify as an endophenotype in some ways like
differentiating groups (Manoach & Agam, 2013; Olvet & Hajcak, 2008; Proudfit et al., 2013),
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few studies have explored criteria necessary to differentiate whether the ERN is better
characterized as a biomarker (Lenzenweger, 2013; Miller & Rockstroh, 2013). Although there is
some variability in the definition of a biomarker (Strimbu & Tavel, 2010), biomarkers are
broadly defined as “indicator[s] of the presence or extent of a biological process that is directly
linked to the clinical manifestations and outcomes of a particular disease (Ritsner & Gottesman,
2009, p. 5-6).” Unlike endophenotypes, biomarkers need not be tied to genetic causes and are
better conceptualized as correlates associated with a disorder (Gould & Gottesman, 2006;
Lenzenweger, 2013; Miller & Rockstroh, 2013). Also, because biomarkers may not fall within
the causal chain from genotype to symptoms, biomarkers can be influenced by state-related
factors such as mood or response to treatment (Lenzenweger, 2013). Thus, in order to
differentiate an endophenotype from a biomarker, it is critical to examine whether a candidate
endophenotype is manifest consistently independent of illness state and whether it demonstrates
patterns of heritability within families.
There is currently relatively little research examining whether ERN amplitude differences
are manifest independent of illness state, or before and after treatment. Most discussion of the
stability of the ERN before and after psychopathology treatment rests on only one study that
found no significant changes in ERN amplitudes among children with OCD before and after
treatment that successfully reduced OCD symptoms (Hajcak et al., 2008), but no research to date
has attempted to replicate study findings in the same population or in other populations. In fact,
Sokhadze, El-Baz, Sears, Opris, and Casanova (2014) observed changes in ERN amplitude that
suggest the ERN might not remain stable following treatment. Specifically, the authors observed
increased ERN amplitudes among children with ASD relative to waitlist comparison subjects
following 18 sessions of repetitive Transcranial Magnetic Stimulation that successfully reduced
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symptoms such as irritability, hyperactivity, and stereotypic behaviors. Given that biomarkers
do not always remain stable following treatment, it is critical to determine whether ERN
amplitudes change following reductions/increases in symptom presentation or whether they
remain stable once an individual crosses over a diagnostic threshold.
Second, additional family studies are also needed to reestablish the heritability of the
ERN, determine whether altered ERN amplitudes co-occur with the disorder in families, and
determine whether altered ERN amplitudes are present in the same form within families of
affected individuals. This is particularly critical in differentiating whether the ERN is an
endophenotype or biomarker, as endophenotypes are associated with pathways from genes to
symptoms but biomarkers may not be as directly tied to genetic risk (Ritsner & Gottesman,
2009). As noted previously, the methodology in most family studies does not fully permit an
examination of the role of kinship status (e.g., Albrecht et al., 2008; Riesel et al., 2011;
Simmonite et al., 2012). The current study is an important first step in examining the ERN
within biologically related families, but additional research within families is necessary to
understand the heritable nature of the ERN and determine the ways in which ERN amplitudes
may signify links between genetics and symptom presentation.
In order to reconcile variability within ERN research and determine whether the ERN is
indeed an endophenotype, we suggest exploring an additional sixth criterion that has been
proposed for a candidate endophenotype: reliability and specificity of measurement (Chan &
Gottesman, 2008; Miller & Rockstroh, 2013). According to this criterion, candidate
endophenotypes should have high sensitivity, meaning that they should be associated with a
disorder more strongly than other conditions (Lenzenweger, 2013; Miller & Rockstroh, 2013).
The findings of the present study and other current research on the ERN reveal inconsistent
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relationships between the ERN and DSM-based diagnostic categories, highlighting the
importance of utilizing research that considers dimensional measures of pathology. Examining
endophenotypes based on categorically defined groups can lead to the tendency to explain results
based on diagnosis, creating a cyclical situation in which a diagnostic “label becomes an
explanation” (Volkmar & McPartland, 2014, p. 196) and thereby validates current diagnostic
criteria instead of providing new information. Also, a more dimensional view of pathology is
consistent with RDoC criteria and may permit researchers to account for underlying traits and
syndromes rather than arbitrary distinctions between disorders, thereby acknowledging that there
are multiple etiological pathways to a set of symptoms (Gould & Gottesman, 2006). A more
dimensional approach applied to the ERN, as was attempted in supplementary analyses in the
current study, may facilitate an enhanced understanding of the pathways that lead to differential
neural activation during performance monitoring (Gould & Gottesman, 2006), resulting in a
broader understanding of the overlap between disorders (Miller & Rockstroh, 2013).
The lack of sensitivity to DSM-based diagnostic criteria may not disqualify the ERN as a
plausible endophenotype, but rather indicate that the ERN is associated with common symptoms
that underlie multiple conditions. Two theories regarding the relationship between underlying
traits and ERN generation have recently been proposed that have promise in determining
whether the ERN is an endophenotype. In a meta-analysis of the relationship between ERN
amplitudes and anxiety, Moser et al. (2013) proposed that the enhanced ERN amplitudes in
anxiety might reflect compensatory error-monitoring processes related to heightened levels of
anxious apprehension. According to this theory, anxious apprehension, or worry, interferes with
attention to goal-directed behaviors by reducing processing efficiency and heightening response
conflict following an error, resulting in enhanced ERN amplitudes (Moser et al., 2013).
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Alternatively, Proudfit et al. (2013) proposed that the ERN signifies broader trait-based levels of
threat sensitivity, with larger-amplitude ERN associated with greater sensitivity to threat. In this
way, the ERN acts as a risk marker for the development of pathology and may be associated with
specific compensatory strategies to reduce/increase threat sensitivity, including worry (Proudfit
et al., 2013). While both theories propose different mechanisms through which anxiety leads to
changes in ERN amplitudes, they similarly suggest that underlying levels of internalizing
symptoms affect performance monitoring.
The compensatory error-monitoring and threat-sensitivity theories of ERN generation and
functional significance are dimensional in nature, as underlying levels of threat sensitivity or
anxious apprehension may result in various symptoms manifest differently based on an
individual’s environment (e.g., learning experiences) or genetic risk. Differences in genetic and
environmental factors may mask the relationship between categorical diagnoses and ERN
amplitude, explaining current variability in ERN amplitudes across diagnoses (Proudfit et al.,
2013). The next step in ERN research should be to examine these hypotheses to determine how
ERN amplitudes are related to genetic risk for anxious apprehension or threat sensitivity and
whether variability in ERN amplitudes signify environmentally derived differences on an
etiological pathway to symptom presentation. Greater understanding of the relationship between
internalizing symptoms and ERN amplitudes may lend important insight into whether the ERN
qualifies as an endophenotype of broader traits that underlie psychopathology.
Anxiety and the ERN in ASD
Given that ERN amplitudes may reflect underlying dimensional trait levels of anxiety, we
explored the relationship between ERN amplitudes and internalizing symptoms among
participants. Individual levels of internalizing symptoms (e.g., anxiety) have been tied to more

63
negative (i.e., greater) ERN amplitudes and may influence ERN presentation in ASD where
anxiety is a frequent comorbidity (Vasa & Mazurek, 2015). The role of individual differences in
state/trait levels of anxiety and comorbid anxiety diagnoses may also in part explain variability in
the literature on ERN amplitudes in ASD.
Although ASD probands displayed significantly higher levels of parent-reported anxiety
than both TDC youth and ASD siblings, we did not observe significant correlations between
SCARED scores and ERN amplitudes in ASD probands alone or in all youth, similar to our
previous work (South et al., 2010). A lack of relationship between anxiety and ASD suggests
that underlying levels of internalizing symptoms may not be related to ERN generation in ASD
and thus may partially explain the lack of group differences in the current sample of ASD youth
relative to control youth. However, our sample only included two ASD probands who reported
comorbid anxiety disorders, possibly limiting our ability to detect the influence of clinical levels
of anxiety on ERN amplitude among youth with ASD.
In contrast, among adults we did observe significant correlations between state levels of
anxiety and ERN amplitudes, with significantly higher levels of state anxiety related to enhanced
ERN amplitudes. The relationship between state-based changes in affect and ERN amplitudes is
not yet clear, as specific state-based manipulations of anxiety do not always relate to changes in
ERN amplitudes (Moser et al., 2013). The threat-sensitivity theory attempts to account for
differences in the literature by proposing that individual levels of threat sensitivity may
determine the degree to which the ERN is influenced by state-related changes in anxiety by
altering the affective value of errors (Proudfit et al., 2013). Individuals with higher levels of
worry may interpret errors as being more threatening, leading to an enhanced ERN (Proudfit et
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al., 2013). Although the measures of anxiety in the current study were not designed to measure
worry, our findings reinforce the general role of anxiety in ERN generation.
Behavioral Performance
In addition to examining ERP indices of performance monitoring, we also examined
behavioral measures. In contrast to our hypotheses, we did not observe significant differences in
RTs or error rates when comparing ASD probands to TDCs. The lack of group differences in
behavior is not surprising given the lack of group differences in neural activation and adds
further support for overall intact performance monitoring processes in our sample of high
functioning youth with ASD relative to control youth.
In behavioral analyses accounting for family and kinship, we did not observe differences
in performance by group or in Group x Kinship interactions. However, parents performed better
than youth, with significantly faster RTs and significantly reduced error rates. These findings are
not unexpected given that greater neural maturity in adults may result in more efficient
information processing and behavioral responses (e.g., Santesso et al., 2006; Wiersema et al.,
2007).
Future Directions
This study represents an important step in ASD research and research on the ERN and Pe
as endophenotypes. Our findings lead to several suggestions for future research in ASD to
understand discrepancies within the literature regarding ERN amplitudes and ASD diagnosis, to
explore the ways in which the Pe reflects underlying traits of ASD, and to examine possible
etiological pathways to neural activation in ASD.
Further research is requisite in order to elucidate if and how ERN and Pe amplitude
differences relate to the symptoms of ASD. As noted, specific combinations of severity across
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social, communication, and restricted/repetitive behavior symptoms may influence ERN and Pe
amplitudes to varying degrees. Also, given the variability in the literature, it is likely that other
factors mediate or moderate the relationship between ASD symptoms and performance
monitoring. These moderating factors may be either state-related factors or trait-based
differences. Thus, we suggest exploring state-based manipulations as well as more trait-based
factors, such as the role of cognitive deficits, comorbid psychological conditions, and alterations
in neural connectivity as potential factors that modulate ERN and Pe amplitudes in ASD.
Accounting for state- and trait-based factors in this way may also reveal diagnostic subgroups
that are generally masked by whole-group analyses.
Future research should also examine the role of task complexity on ERN/Pe generation
and behavior in ASD. If theories of connectivity in ASD are correct, individuals with ASD may
have increasing difficulty with tasks that involve greater cognitive demand. Examining
cognitive and neural processes during tasks of varying levels of complexity that tap into different
skills (e.g., social and emotional functioning, executive functioning) may reveal whether
individuals with ASD have a threshold of ability above which they are unable to perform at the
same level as TDCs. Further, incorporating ERP research with measures of neural connectivity
(e.g., DTI) may further reveal if and when individuals with ASD utilize compensatory neural
activity between neural regions to achieve similar performance.
Another important consideration for future research is conducting more studies that
specifically examine whether the ERN is sensitive to a more general underlying trait, such as
those proposed in the compensatory error-monitoring hypothesis or the threat-sensitivity
hypotheses. Researchers should apply both theories to ASD specifically by measuring worry or
threat-sensitivity in order to understand to what degree anxiety influences the ERN in ASD. It
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may be particularly beneficial to compare ERN amplitudes among individuals with anxiety, ASD
probands, and ASD probands with comorbid anxiety disorders in order to determine whether
clinical levels of anxiety differentially affect ASD-related performance monitoring abilities and
neural processes. It is possible that anxiety enhances an already reduced ERN in ASD, resulting
in ERNs that, at times, appear comparable to TDCs.
Finally, the observed relationship between Pe amplitudes and symptoms of ASD should
be explored further. If reduced Pe amplitudes are related to symptoms of ASD, future research
should explore what specific symptoms influence Pe amplitudes (e.g., social deficits,
communication deficits, reduced executive functioning, etc.) and to what degree these symptoms
must be present to significantly alter error awareness. Given that Pe amplitudes were also
significantly correlated with anxiety, it may be that the specific interaction between heightened
levels of anxiety and subthreshold symptoms of ASD be associated with reduced error
awareness.
Limitations
Several limitations should be considered when interpreting the results of the current
study. First, our study had a substantial amount of missing data due to participant dropout,
excessive movement artifact during EEG acquisition, low rates of error commission, and missing
surveys from families. The missing data in our study resulted in relatively small groups for each
cell during analyses. Excessive movement artifact in part reflects challenges of EEG data
acquisition among children with ASD who may have greater difficulty remaining still and may
experience increased discomfort during net application due to sensory sensitivities. The nature
of the task may have also played a role, as it is possible that we did not obtain high enough error
rates for some participants due to the ease of the task. We attempted to utilize a task that was
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cognitively demanding and that had enough trials to challenge adult participants but that did not
exceed levels appropriate for youth participants. Determining an appropriate level of difficulty
for both adult and youth participants is an important consideration moving forward, particularly
as additional research is conducted to include comparisons within families.
Second, our sample of individuals with ASD was high functioning, with IQs in the
average to above-average range. Overall levels of intellectual functioning may play a role in
ERN generation, as differences in overall cognitive capacity may influence the efficiency of
performance monitoring. Henderson et al. (2006) observed a significant relationship between
ERN amplitudes and VIQ scores, with enhanced ERN amplitudes observed among children with
higher VIQ scores. The relationship between VIQ and ERN amplitudes was not replicated in the
current study or past studies (South et al., 2010; Vlamings et al., 2008). Research consistently
suggests that overall IQ is predictive of long-term outcomes in ASD (Magiati, Tay, & Howlin,
2014) and may underlie some of the heterogeneity in symptom presentation and severity. The
relationship between IQ and functional outcomes in ASD may indicate that the sample of
children and adults included in the current study represents a separate, distinct portion of the
ASD population. The lack of group differences in neural activation observed among these
individuals may not be representative of the overall population of individuals with ASD.
Similarly, we did not observe the expected pattern of symptoms of the broader autism
phenotype among relatives of ASD probands. Regression analyses examining group and kinship
differences on the AQ and BAPQ were not significant, suggesting that relatives of ASD
probands included in the current study may not have displayed heightened levels of the broader
autism phenotype as observed in other samples (Hurley et al., 2007; Ingersoll, Hopwood,
Wainer, & Donnellan, 2011; Sasson et al., 2013). Indeed, average AQ and BAPQ scores among
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mothers and fathers of ASD probands and ASD siblings did not meet established cutoffs of
32/30 (females/males) or 3.15, respectively, for the broader autism phenotype (Baron-Cohen et
al., 2006; Baron-Cohen et al., 2001; Hurley et al., 2007). However, in regressions examining
SRS-II scores we did observe the expected pattern of significantly higher levels of ASD
symptoms among individuals with ASD relative to all other groups and among unaffected
relatives of ASD probands relative to control families. Thus, relatives of ASD probands did not
display differences on measures of the broader autism phenotype but did display differences on a
dimensional measure of ASD symptoms, possibly suggesting that our sample of unaffected ASD
relatives were higher functioning and displayed overall fewer subthreshold symptoms of ASD.
Lower than anticipated levels of ASD symptoms seen in relatives may in part reflect
measurement error. We utilized different rating sources for the AQ/BAPQ and SRS-II among
parents. The AQ and BAPQ involved self-report ratings of behavior, while SRS-II scores
involved spouse-report ratings of behavior. Previous research documents differences based on
the rater, suggesting that observed discrepancies may reflect differences in self-perception of
symptoms (Hurley et al., 2007; Seidman, Yirmiya, Milshtein, Ebstein, & Levi, 2011). In
addition, though the concurrent validity of the AQ, SRS, and BAPQ has been previously
established in a non-clinical sample (Ingersoll et al., 2011), no studies have examined the
concurrent validity in a sample that included unaffected relatives of ASD probands. Ingersoll et
al. (2011) suggested that “the BAPQ is more closely related to the defining features of the
[broader autism phenotype], whereas the SRS-A is more closely related to peripheral features of
the phenotype, and may be indicative of psychopathology more generally” (p. 1654). Thus, the
observed discrepancy between SRS-II and AQ/BAPQ scores may also reflect overall greater
levels of pathology in ASD relatives rather than greater symptoms of ASD severity.
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Finally, a large proportion of participants in the current study were taking psychotropic
medications at the time of study participation. There is some evidence that medication use may
influence ERN amplitudes (Barnes, O'Connell, Nandam, Dean, & Bellgrove, 2014; de Bruijn,
Hulstijn, Verkes, Ruigt, & Sabbe, 2004; de Bruijn, Sabbe, Hulstijn, Ruigt, & Verkes, 2006;
Groen et al., 2008; Riba, Rodriguez-Fornells, Münte, & Barbanoj, 2005). Previous research in
ASD also suggests some differences based on medication status (Henderson et al., 2006), though
this has not been replicated in all studies (Santesso et al., 2011; South et al., 2010). Thus, it is
possible that psychotropic medication use influenced the observed findings.
Conclusion
In summary, this is the first study to examine the ERN and Pe in biologically related
families, permitting an examination of the role of heritability and kinship status. We utilized
group and kinship as predictors in regressions in order to examine differences in the familial
aggregation of ERN amplitudes and included families as clusters in order to account for shared
variance due to family membership. Results only partially followed predictions. Error-related
negativity and Pe amplitudes among youth with ASD were not significantly different from
control youth, and group and kinship status did not predict ΔERN amplitudes or ΔPe amplitudes.
Thus, we did not find support for the ERN or Pe as endophenotypes or biomarkers of ASD,
though the Pe may be influenced by symptoms of ASD. Similarly, group and kinship did not
predict behavioral data aside from significantly better performance in adults relative to youth,
regardless of group status. Our findings suggest the need for additional studies of the ERN as an
endophenotype of pathology that determine the reliability and specificity of the ERN in relation
to dimensional, syndrome-based components of pathology.

70
References
Agam, Y., Joseph, R. M., Barton, J. J. S., & Manoach, D. S. (2010). Reduced cognitive control
of response inhibition by the anterior cingulate cortex in autism spectrum disorders.
Neuroimage, 52, 336-347. doi: 10.1016/j.neuroimage.2010.04.010
Ahmed, A. A., & Vander Wyk, B. C. (2013). Neural processing of intentional biological motion
in unaffected siblings of children with autism spectrum disorder: An fMRI study. Brain
and Cognition, 83, 297-306. doi: 10.1016/j.bandc.2013.09.007
Albrecht, B., Brandeis, D., Uebel, H., Heinrich, H., Mueller, U. C., Hasselhorn, M., . . .
Banaschewski, T. (2008). Action monitoring in boys with attention-deficit/hyperactivity
disorder, their nonaffected siblings, and normal control subjects: Evidence for an
endophenotype. Biological Psychiatry, 64, 615-625. doi: 10.1016/j.biopsych.2007.12.016
Ameis, S. H., & Catani, M. (2015). Altered white matter connectivity as a neural substrate for
social impairment in Autism Spectrum Disorder. Cortex, 62, 158-181. doi:
10.1016/j.cortex.2014.10.014
Amodio, D. M., Master, S. L., Yee, C. M., & Taylor, S. E. (2008). Neurocognitive components
of the behavioral inhibition and activation systems: Implications for theories of selfregulation. Psychophysiology, 45, 11-19. doi: 10.1111/j.1469-8986.2007.00609.x
Anderson, J. S., Nielsen, J. A., Froehlich, A. L., DuBray, M. B., Druzgal, T. J., Cariello, A. N., .
. . Lainhart, J. E. (2011). Functional connectivity magnetic resonance imaging
classification of autism. Brain, 134, 3742-3754. doi: 10.1093/brain/awr263
Anokhin, A. P., Golosheykin, S., & Heath, A. C. (2008). Heritability of frontal brain function
related to action monitoring. Psychophysiology, 45, 524-534. doi: 10.1111/j.14698986.2008.00664.

71
Ari, B., & Güvenir, H. A. (2002). Clustered linear regression. Knowledge-Based Systems, 15,
169-175. doi: 10.1016/S0950-7051(01)00154-X
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition. Washington, DC: American Psychiatric Press.
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M.
(1995). Autism as a strongly genetic disorder: Evidence from a British twin study.
Psychological Medicine, 25, 63-77. doi: 10.1017/S0033291700028099
Baldwin, S. A., Larson, M. J., & Clayson, P. E. (in press). The dependability of
electrophysiological measurements of performance monitoring in a clinical sample: A
generalizability and decision analysis of the ERN and Pe. Psychophysiology. doi:
10.1111/psyp.12401
Barnby, G., Abbott, A., Sykes, N., Morris, A., Weeks, D. E., Mott, R., . . . Monaco, A. P. (2005).
Candidate-gene screening and association analysis at the autism-susceptibility locus on
chromosome 16p: Evidence of association at GRIN2A and ABAT. American Journal of
Human Genetics, 76, 950-966. doi: 10.1086/430454
Barnea-Goraly, N., Lotspeich, L. J., & Reiss, A. L. (2010). Similar white matter aberrations in
children with autism and their unaffected siblings: A diffusion tensor imaging study using
tract-based spatial statistics. Archives of General Psychiatry, 67, 1052-1060. doi:
10.1001/archgenpsychiatry.2010.123
Barnes, J. J., O'Connell, R. G., Nandam, L. S., Dean, A. J., & Bellgrove, M. A. (2014).
Monoaminergic modulation of behavioural and electrophysiological indices of error
processing. Psychopharmacology, 231, 379-392. doi: 10.1007/s00213-013-3246-y

72
Baron-Cohen, S., Hoekstra, R. A., Knickmeyer, R., & Wheelwright, S. (2006). The Autism
Spectrum Quotient (AQ)--Adolescent Version. Journal of Autism and Developmental
Disorders, 36, 343-350. doi: 10.1007/s10803-006-0073-6
Baron-Cohen, S., Wheelright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The AutismSpectrum Quotient (AQ): Evidence from Asperger syndrome/high-functioning autism,
males and females, scientists and mathematicians. Journal of Autism and Developmental
Disorders, 31, 5-17. doi: 10.1023/A:1005653411471
Beck, A. T. (1996). Beck Depression Inventory - Second Edition (BDI-II). USA: The
Psychological Corporation.
Belmonte, M. K., Allen, G., Beckel-Mitchener, A., Boulanger, L. M., Carper, R. A., & Webb, S.
J. (2004). Autism and abnormal development of brain connectivity. The Journal of
Neuroscience, 24, 9228-9231. doi: 10.1523/JNEUROSCI.3340-04.2004
Belmonte, M. K., Gomot, M., & Baron-Cohen, S. (2010). Visual attention in autism families:
'Unaffected' sibs share atypical frontal activation. Journal of Child Psychology and
Psychiatry, 51, 259-276. doi: 10.1111/j.1469-7610.2009.02153.
Betancur, C. (2011). Etiological heterogenity in autism spectrum disorders: More than 100
genetic and genomic disorders and still counting. Brain Research, 1380, 42-77. doi:
10.1016/j.brainres.2010.11.078
Birmaher, B., Khetarpal, S., Cully, M., Balach, L., Kaufman, J., & Neer, S. M. (1997). The
Screen for Child Anxiety Related Emotional Disorders (SCARED): Scale construction
and psychometric characteristics. Journal of the American Academy of Child and
Adolescent Psychiatry 36, 545-553. doi: 10.1097/00004583-199704000-00018

73
Bishop, D. V. M., Maybery, M., Wong, D., Maley, A., & Hallmayer, J. (2006). Characteristics of
the broader phenotype in autism: A study of siblings using the Children's Communication
Checklist-2. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
141B, 117-122. doi: 10.1002/ajmg.b.30267
Bosl, W., Tierney, A., Tager-Flusberg, H., & Nelson, C. (2011). EEG complexity as a biomarker
for autism spectrum disorder risk. BMC Medicine, 9, 18. doi: 10.1186/1741-7015-9-18
Botvinick, M., Carter, C. S., Braver, T. S., Barch, D. M., & Cohen, J. D. (2001). Conflict
monitoring and cognitive control. Psychological Review, 108, 624-652. doi:
10.1037/0033-295X.108.3.624
Bramon, E., Croft, R. J., McDonald, C., Virdi, G. K., Gruzelier, J. G., Baldeweg, T., . . . Murray,
R. M. (2004). Mismatch negativity in schizophrenia: A family study. Schizophrenia
Research 67, 1-10. doi: 10.1016/S0920-9964(03)00132-4
Bush, G., Luu, P., & Posner, M. I. (2000). Cognitive and emotional influences in anterior
cingulate cortex. Trends in Cognitive Sciences, 4, 215-222. doi: 10.1016/s13646613(00)01483-2
Cannon, T. D., & Keller, M. C. (2006). Endophenotypes in the genetic analysis of mental
disorders. Annual Reviews of Clinical Psychology, 2, 267-290. doi:
10.1146/annurev.clinpsy.2.022305.095232
Carrasco, M., Harbin, S. M., Nienhus, J. K., Fitzgerald, K. D., Gehring, W. J., & Hanna, G. L.
(2013). Increased error-related brain activity in youth with obsessive-compulsive disorder
and unaffected siblings. Depression and Anxiety, 30, 39-46. doi: 10.1002/da.22035

74
Carter, C. S., Braver, T. S., Barch, D. M., Botvinick, M., Ross, L. L., Stenger, V. A., . . . Cohen,
J. D. (1998). Anterior cingulate cortex, error detection, and the online monitoring of
performance. Science, 280, 747-749. doi: 10.1126/science.280.5364.747
Chan, R. C. K., & Gottesman, I. I. (2008). Neurological soft signs as candidate endophenotypes
for schizophrenia: A shooting star or a Northern star? Neuroscience and Biobehavioral
Reviews, 32, 957-971. doi: 10.1016/j.neubiorev.2008.01.005
Cheng, W., Rolls, E. T., Gu, H., Zhang, J., & Feng, J. (in press). Autism: Reduced connectivity
between cortical areas involved in face expression, theory of mind, and the sense of self.
Brain. doi: 10.1093/brain/awv051
Chiu, P. H., & Deldin, P. J. (2007). Neural evidence for enhanced error detection in major
depressive disorder. American Journal of Psychiatry, 164, 608-616. doi:
10.1176/appi.ajp.164.4.608
Christ, S. E., Kester, L. E., Bodner, K. E., & Miles, J. H. (2011). Evidence for selective
inhibitory impairment in individuals with autism spectrum disorder. Neuropsychology 25,
690-701. doi: 10.1037/a0024256
Clawson, A., Clayson, P. E., South, M., Bigler, E. D., & Larson, M. J. (2015). An
electrophysiological investigation of interhemispheric transfer time in children and
adolescents with high-functioning autism spectrum disorders. Journal of Autism and
Developmental Disorders, 45, 365-375. doi: 10.1007/s10803-013-1895-7
Clayson, P. E., Baldwin, S. A., & Larson, M. J. (2013). How does noise affect amplitude and
latency measurement of event-related potentials (ERPs)? A methodological critique and
simulation study. Psychophysiology, 50, 174-186. doi: 10.1111/psyp.12001

75
Clayson, P. E., Clawson, A., & Larson, M. J. (2011). Sex differences in electrophysiological
indices of conflict monitoring. Biological Psychology, 87, 282-289. doi:
10.1016/j.biopsycho.2011.03.011
Clayson, P. E., Clawson, A., & Larson, M. J. (2012). The effects of induced state negative affect
on performance monitoring processes. Social Cognitive and Affective Neuroscience, 7,
677-688. doi: 10.1093/scan/nsr040
Colvert, E., Tick, B., McEwen, F., Stewart, C., Curran, S. R., Woodhouse, E., . . . Bolton, P. (in
press). Heritability of autism spectrum disorder in a UK population-based twin sample.
JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2014.3028
Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., . . .
Reich, W. (2003). Validation of a brief quantitative measure of autistic traits:
Comparison of the Social Responsiveness Scale with the Autism Diagnostic InterviewRevised. Journal of Autism and Developmental Disorders, 33, 427-433. doi:
10.1023/A:1025014929212
Constantino, J. N., Zhant, Y., Frazier, T. W., Abbacchi, A. M., & Law, P. (2010). Sibling
recurrence and the genetic epidemiology of autism. American Journal of Psychiatry, 167,
1349-1356. doi: 10.1176/appi.ajp.2010.09101470
Corsello, C., Hus, V., Pickles, A., Risi, S., Cook, E., Leventhal, B., & Lord, C. (2007). Between
a ROC and a hard place: Decision making and making decisions using the SCQ. Journal
of Child Psychology and Psychiatry, 48, 932-940. doi: 10.1111/j.14697610.2007.01762.x
Courchesne, E., Mouton, P. R., Calhoun, M. E., Semendeferi, K., Ahrens-Barbeau, C., Hallet, M.
J., . . . Pierce, K. (2011). Neuron number and size in prefrontal cortex of children with

76
autism. JAMA: The Journal of the American Medical Association, 306, 2001-2010. doi:
10.1001/jama.2011.1638
Dawson, G., Webb, S. J., Schellenberg, G. D., Dager, S., Friedman, S., Aylward, E., & Richards,
T. (2002). Defining the broader phenotype of autism: Genetic, brain, and behavioral
perspectives. Developmental Psychopathology, 14, 581-611. doi:
10.1017/S0954579402003103
de Bruijn, E. R. A., Hulstijn, W., Verkes, R. J., Ruigt, G. S. F., & Sabbe, B. G. C. (2004). Druginduced stimulation and suppression of action monitoring in healthy volunteers.
Psychopharmacology, 177, 151-160. doi: 10.1007/s00213-004-1915-6
de Bruijn, E. R. A., Sabbe, B. G. C., Hulstijn, W., Ruigt, G. S. F., & Verkes, R. J. (2006). Effects
of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers.
Brain Research, 1105, 122-129. doi: 10.1016/j.brainres.2006.01.006
de Geus, E. J. (2010). From genotype to EEG endophenotype: A route for post-genomic
understanding of complex psychiatric disease? Genome Medicine, 2, 63. doi:
10.1186/gm184
De la Marche, W., Noens, I., Luts, J., Scholte, E., Van Huffel, S., & Steyaert, J. (2012).
Quantitative autism traits in first degree relatives: Evidence for the broader autism
phenotype in fathers, but not in mothers and siblings. Autism, 16, 247-260. doi:
10.1177/1362361311421776
Delmonte, S., Gallagher, L., O'Hanlon, E., McGrath, J., & Balsters, J. H. (2013). Functional and
structural connectivity of frontostriatal circuitry in Autism Spectrum Disorder. Frontiers
in Human Neuroscience, 7, 1-14. doi: 10.3389/fnhum.2013.00430

77
Delorme, A., & Makeig, S. (2004). EEGLAB: An open source toolbox for analysis of single-trial
EEG dynamics including independent component analysis. Journal of Neuroscience
Methods, 134, 9-21. doi: 10.1016/j.jneumeth.2003.10.009
Delorme, R., Goussé, V., Roy, I., Trandafir, A., Mathieu, F., Mouren-Siméoni, M., . . . Leboyer,
M. (2007). Shared executive dysfunctions in unaffected relatives of patients with autism
and obsessive-compulsive disorder. European Psychiatry, 22, 32-38. doi:
10.1016/j.eurpsy.2006.05.002
Dien, J. (2010). The ERP PCA Toolkit: An open source program for advanced statistical analysis
of event-related potential data. Journal of Neuroscience Methods, 187, 138-145. doi:
10.1016/j.jneumeth.2009.12.009
Dien, J., Franklin, M. S., & May, C. J. (2006). Is "Blank" a suitable neutral prime for eventrelated potential experiments? Brain and Language, 97, 91-101. doi:
10.1016/j.bandl.2005.08.002
Dien, J., Michelson, C. A., & Franklin, M. S. (2010). Separating the visual sentence N400 effect
from the P400 sequential expectancy effect: Cognitive and neuroanatomical implications.
Brain Research, 1355, 126-140. doi: 10.1016/j.brainres.2010.07.099
Eapen, V. (2011). Genetic basis of autism: Is there a way forward? Current Opinion in
Psychiatry, 24, 226-236. doi: 10.1097/YCO.0b013e328345927e
Endrass, T., Klawohn, J., Schuster, F., & Kathmann, N. (2008). Overactive performance
monitoring in obsessive-compulsive disorder: ERP evidence from correct and erroneous
reactions. Neuropsychologia, 46, 1877-1887. doi:
10.1016/j.neuropsychologia.2007.12.001

78
Endrass, T., Reuter, B., & Kathmann, N. (2007). ERP correlates of conscious error recognition:
Aware and unaware errors in an antisaccade task. European Journal of Neuroscience, 26,
1714-1720. doi: 10.1111/j.1460-9568.2007.05785.x
Endrass, T., Schuermann, B., Kaufmann, C., Spielberg, R., Kniesche, R., & Kathmann, N.
(2010). Performance monitoring and error significance in patients with obsessivecompulsive disorder. Biological Psychology, 84, 257-263. doi:
10.1016/j.biopsycho.2010.02.002
Eriksen, B. A., & Eriksen, C. W. (1974). Effects of noise letters upon the identification of a
target letter in a non-search task. Perception & Psychophysics, 16, 143-149.
Euser, A. S., Evans, B. E., Greaves-Lord, K., Huizink, A. C., & Franken, I. H. (2012).
Diminished error-related brain activity as a promising endophenotype for substance-use
disorders: Evidence from high-risk offspring. Addiction Biology, 18, 970-984. doi:
10.1016/j.biopsych.2007.12.016
Eysenck, M. W., Derakshan, N., Santos, R., & Calvo, M. G. (2007). Anxiety and cognitive
performance: Attentional control theory. Emotion, 7, 336-353. doi: 10.1037/15283542.7.2.336
Falkenstein, M., Hohnsbein, J., Hoormann, J., & Banke, L. (1991). Effects of crossmodal divided
attention on late ERP components. II. Error processing in choice reaction tasks.
Electroencephalography and Clinical Neurophysiology, 78, 447-455. doi: 10.1016/00134694(91)90062-9
Falkenstein, M., Hoormann, J., Christ, S., & Hohnsbein, J. (2000). ERP components on reaction
errors and their functional significance: A tutorial. Biological Psychology, 51, 87-107.
doi: 10.1016/S0301-0511(99)00031-9

79
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., . . . Buxbaum, J.
D. (2014). Most genetic risk for autism resides with common variation. Nature Genetics,
46, 881-885. doi: 10.1038/ng.3039
Gehring, W. J., Goss, B., Coles, M. G. H., Meyer, D. E., & Donchin, E. (1993). A neural system
for error detection and compensation. Psychological Science, 4, 385-390. doi:
10.1111/j.1467-9280.1993.tb00586.x
Glahn, D., Thompson, P. M., & Blangero, J. (2007). Neuroimaging endophenotypes: Strategies
for finding genes influencing brain structure and function. Human Brain Mapping, 28,
488-501. doi: 10.1002/hbm.20401
Goin-Kochel, R. P., Abacchi, A., & Constantino, J. N. (2007). Lack of evidence for increased
genetic loading for autism among families of affected females: A replicaiton from family
history data in two large samples. Autism: The International Journal of Research and
Practice, 11, 279-286. doi: 10.1177/1362361307076857
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: Etymology
and strategic intentions. American Journal of Psychiatry, 160, 636-645. doi:
10.1176/appi.ajp.160.4.636
Gould, T. D., & Gottesman, I. (2006). Psychiatric endophenotypes and the development of valid
animal models. Genes, Brain and Behavior, 5, 113-119. doi: 10.1111/j.1601183X.2005.00186.x
Griebling, B. S., Minshew, N. J., Bodner, K., Libove, R., Bansal, R., Konasale, P., . . . Hardan,
A. (2010). Dorsolateral prefrontal cortex magnetic resonance imaging measurements and
cognitive performance in autism. Journal of Child Neurology, 27, 856-863. doi:
10.1177/0883073809351313

80
Groen, Y., Wijers, A. A., Mulder, L. J. M., Waggeveld, B., Minderaa, R. B., & Althaus, M.
(2008). Error and feedback processing in children with ADHD and children with Autistic
Spectrum Disorder: An EEG event-related potential study. Clinical Neurophysiology,
119, 2476-2493. doi: 10.1016/j.clinph.2008.08.004
Hajcak, G., Franklin, M. E., Foa, E. B., & Simons, R. F. (2008). Increased error-related brain
activity in pediatric obsessive-compulsive disorder before and after treatment. American
Journal of Psychiatry, 165, 116-123. doi: 10.1176/appi.ajp.2007.07010143
Hajcak, G., McDonald, N., & Simons, R. F. (2003). Anxiety and error-related brain activity.
Biological Psychology, 64, 77-90. doi: 10.1016/S0301-0511(03)00103-0
Hajcak, G., McDonald, N., & Simons, R. F. (2004). Error-related psychophysiology and negative
affect. Brain and Cognition, 56, 189-197. doi: 10.1016/j.bandc.2003.11.001
Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., . . . Risch, N. (2011).
Genetic heritability and shared environmental factors among twin pairs with autism.
Archives of General Psychiatry, 68, 1095-1102. doi: 10.1001/archgenpsychiatry.2011.76
Happé, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation for autism.
Nature Neuroscience, 9, 1218-1220. doi: 10.1038/nn1770
Haznedar, M. M., Buchsbaum, M. S., Wei, T. C., Hof, P. R., Cartwright, C., Bienstock, C. A., &
Hollander, E. (2000). Limbic circuitry in patients with autism spectrum disorders studied
with positron emission tomography and magnetic resonance imaging. The American
Journal Of Psychiatry, 157, 1994-2001. doi: 10.1176/appi.ajp.157.12.1994
Henderson, H., Ono, K. E., McMahon, C. M., Schwartz, C. B., Usher, L. V., & Mundy, P. C.
(2015). The costs and benefits of self-monitoring for higher funcitoning children and

81
adolescents with autism. Journal of Autism and Developmental Disorders, 45, 548-559.
doi: 10.1007/s10803-013-1968-7
Henderson, H., Schwartz, C., Mundy, P., Burnette, C., Sutton, S., Zahka, N., & Pradella, A.
(2006). Response monitoring, the error-related negativity, and differences in social
behavior in autism. Brain and Cognition, 61, 96-109. doi: 10.1016/j.bandc.2005.12.009
Herrmann, M. J., Römmler, J., Ehlis, A., Heidrich, A., & Fallgatter, A. J. (2004). Source
localization (LORETA) of the error-related-negativity (ERN/Ne) and positivity (Pe).
Cognitive Brain Research, 20, 294-299. doi: 10.1016/j.cogbrainres.2004.02.013
Herwig, U., Baumgartner, T., Kaffenberger, T., & Brühl, A. (2007). Modulation of anticipatory
emotion and perception processing by cognitive control. Neuroimage, 37, 652-662. doi:
10.1016/j.neuroimage.2007.05.023
Holroyd, C. B., & Coles, M. G. H. (2002). The neural basis of human error processing:
Reinforcement learning, dopamine, and the error-related negativity. Psychological
Review, 109, 679-709. doi: 10.1037/0033-295x.109.4.679
Huffmeijer, R., Bakermans-Kranenburg, M. J., Alink, L. R., & van Ijzendoorn, M. H. (2014).
Reliability of event-related potentials: The influence of number of trials and electrodes.
Physiology and Behavior, 10, 13-22. doi: 10.1016/j.physbeh.2014.03.008
Hughes, C., Leboyer, M., & Bouvard, M. (1997). Executive function in parents of children with
autism. Psychological Medicine, 27, 209-220. doi: 10.1017/S0033291796004308
Hurley, R. S. E., Losh, M., Parlier, M., Reznick, J. S., & Piven, J. (2007). The broad autism
phenotype questionnaire. Journal of Autism and Developmental Disorders, 37, 16791690. doi: 10.1007/s10803-006-0299-3
IBMCorp. (2013). IBM SPSS Satatistics, Version 22.0. Armonk, NY: IBM Corp.

82
Ingersoll, B., Hopwood, C. J., Wainer, A., & Donnellan, M. B. (2011). A comparison of three
self-report measures of the broader autism phenotype in a non-clinical sample. Journal of
Autism and Developmental Disorders, 4, 1646-1657. doi: 10.1007/s10803-011-1192-2
Insel, T. R., & Cuthbert, B. N. (2009). Endophenotypes: Bridging genomic complexity and
disorder heterogeneity. Biological Psychiatry, 66, 988-989. doi:
10.1016/j.biopsych.2009.10.008
Jeste, S. S., & Nelson, C. A. (2009). Event related potentials in the understanding of autism
spectrum disorders: An analytical review. Journal of Autism and Developmental
Disorders, 39, 495-510. doi: 10.1007/s10803-008-0652-9
Just, M. A., Cherkassky, V. L., Keller, T. A., Kana, R. K., & Minshew, N. J. (2007). Functional
and anatomical cortical underconnectivity in autism: Evidence from an fMRI study of an
executive function task and corpus callosum morphometry. Cerebral Cortex, 17, 951961. doi: 10.1093/cercor/bhl006
Kaiser, M. D., Hudac, C. M., Schultz, S., Lee, S. M., Cheung, C., Berken, A. M., . . . Pelphrey,
K. A. (2010). Neural signatures of autism. Proceedings of the National Academy of
Sciences, 107, 21223-21228. doi: 10.1073/pnas.1010412107
Kana, R. K., Keller, K., Minshew, N. J., & Just, M. A. (2007). Inhibitory control in highfunctioning autism: Decreased activation and underconnectivity in inhibition networks.
Biological Psychiatry, 62, 198-206. doi: 10.1016/j.biopsych.2006.08.004
Kana, R. K., Libero, L. E., & Moore, M. S. (2011). Disrupted coritcal connectivity theory as an
explanatory model for autism spectrum disorders. Physics of Life Reveiws, 8, 410-437.
doi: 10.1016/j.plrev.2011.10.001

83
Keselman, H. J. (1998). Testing treatment effects in repeated measures designs: An update for
psychophysiological researchers. Psychophysiology, 35, 470-478.
Keselman, H. J., Wilcox, R. R., & Lix, L. M. (2003). A generally robust approach to hypothesis
testing in independent and correlated groups designs. Psychophysiology, 40, 586-596.
doi: 10.1037/1082-989X.13.2.110
Kiser, D. P., Rivero, O., & Lesch, K. (2015). Annual research review: The (epi)genetics of
neurodevelopmental disorders in the era of whole-genome sequencing-unveiling the dark
matter. Journal of Child Psychology and Psychiatry 56, 278-295. doi:
10.1111/jcpp.12392
Klei, L., Sanders, S. J., Murtha, M. T., Hus, V., Lowe, J. K., Willsey, A. J., . . . Devlin, B.
(2012). Common genetic variants, acting additively, are a major source of risk for autism.
Molecular Autism, 3, 9. doi: 10.1186/2040-2392-3-9
Kleinbaum, D. G., Kupper, L. L., Muller, K. E., & Nizam, A. (2007). Applied regression
analysis and other multivariate methods (Fourth Edition ed.). Boston: Duxbury Press.
Kumar, R. A., Sudi, J., Babatz, T. D., Brune, C. W., Oswald, D., Yen, M., . . . Dobyns, W. B.
(2010). A de novo 1qp34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a
novel candidate for autism. Journal of Medical Genetics, 47, 81-90. doi:
10.1136/jmg.2008.065821
Ladouceur, C. D., Dahl, R. E., & Carter, C. S. (2007). Development of action monitoring
through adolescence into adulthood: ERP and source localization. Developmental
Science, 10, 874-891. doi: 10.1111/j.1467-7687.2007.00639.x

84
Larson, M. J., Clayson, P. E., & Clawson, A. (2014). Making sense of all the conflict: A
theoretical review and critique of conflict-related ERPs. International Journal of
Psychophysiology 93, 283-297. doi: 10.1016/j.ijpsycho.2014.06.007
Larson, M. J., South, M., & Clayson, P. E. (2011). Sex differences in error-related performance
monitoring. Neuroreport, 22, 44-48. doi: 10.1097/WNR.0b013e3283427403
Larson, M. J., South, M., Clayson, P. E., & Clawson, A. (2012). Cognitive control and conflict
adaptation in youth with high-functioning autism. Journal of Child Psychology and
Psychiatry, 53, 440-448. doi: 10.1111/j.1469-7610.2011.02498.x
Lee, M., Rebora, P., Valsecchi, M. G., Czene, K., & Reilly, M. (2013). A unified model for
estimating and testing familial aggregation. Statistics in Medicine, 32, 5353-5365. doi:
10.1002/sim.6025
Lenzenweger, M. F. (2013). Endophenotype, intermediate phenotype, biomarker: Definitions,
concept comparisons, clarifications. Depression and Anxiety, 30, 185-189. doi:
10.1002/da.22042
Leung, R. C., Vogan, V. M., Powell, T. L., Anagnostou, E., & Taylor, M. L. (2015). The role of
executive functions in social impairment in Autism Spectrum Disorder. Child
Neuropsychology, 3, 1-9. doi: 10.1080/09297049.2015.1005066
Li, X., Zou, H., & Brown, T. W. (2012). Genes associated with autism spectrum disorder. Brain
Research Bulletin, 88, 543-552. doi: 10.1016/j.brainresbull.2012.05.017
Lichtenstein, P., Carlström, E., Råstam, M., Gillberg, C., & Anckarsäter, H. (2010). The genetics
of autism spectrum disorders and related neuropsychiatric disorders in childhood.
American Journal of Psychiatry, 167, 1357-1363. doi: 10.1176/appi.ajp.2010.10020223

85
Liu, X., & Takumi, T. (2014). Genomic and genetic aspects of autism spectrum disorder.
Biochemical and Biophysical Research Communications, 452, 244-253. doi:
10.1016/j.bbrc.2014.08.108
Lord, C., & Bishop, S. L. (2015). Recent advances in autism research as reflected in DSM-5
criteria for autism spectrum disorder. Annual Review of Clinical Psychology, 11, 53-70.
doi: 10.1146/annurev-clinpsy-032814-112745
Lord, C., & Jones, R. M. (2012). Annual research review: Re-thinking the classification of
autism spectrum disorders. The Journal of Child Psychology and Psychiatry, 53, 490509. doi: 10.1111/j.1469-7610.2012.02547.x
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., . . . Rutter, M.
(2000). The autism diagnostic observation schedule-generic: A standard measure of
social and communication deficits associated with the spectrum of autism. Journal of
Autism and Developmental Disorders, 30, 205-223. doi: 10.1023/A:1005592401947
Losh, M., Sullivan, P. F., Trembath, D., & Piven, J. (2008). Current developments in the genetics
of autism: From phenome to genome. Journal of Neuropathology and Experimental
Neurology, 67, 829-837. doi: 10.1097/NEN.0b013e318184482d
Magiati, I., Tay, X. W., & Howlin, P. (2014). Cognitive, language, social and behavioural
outcomes in adults with autism spectrum disorders: A systematic review of longitudinal
follow-up studies in adulthood. Clinical Psychology Review, 34, 73-86. doi:
10.1016/j.cpr.2013.11.002
Manoach, D. S., & Agam, Y. (2013). Neural markers of errors as endophenotypes in
neuropsychiatric disorders. Frontiers in Human Neuroscience 7, 350. doi:
10.3389/fnhum.2013.00350

86
McLoughlin, G., Albrecht, B., Banaschewski, T., Rothenberger, A., Brandeis, D., Asherson, P.,
& Kuntsi, J. (2009). Performance monitoring is altered in adult ADHD: A familial eventrelated potential investigation Neuropsychologia, 47, 3134-3142. doi:
10.1016/j.neuropsychologia.2009.07.013
McMahon, C. M., & Henderson, H. A. (2014). Error-monitoring in response to social stimuli in
individuals with higher-functioning Autism Spectrum Disorder. Developmental Science,
28, 1-15. doi: 10.1111/desc.12220
Miller, G. A., & Rockstroh, B. (2013). Endophenotypes in psychopathology research: Where do
we stand? Annual Reviews of Clinical Psychology, 9, 177-213. doi: 10.1146/annurevclinpsy-050212-185540
Minshew, N. J., & Williams, D. L. (2006). Brain behavior connections in autism. In K. D. Buron
& P. Wolfberg (Eds.), Educating learners on the autism spectrum: Translating theory
into meaningful practice. Shawnee, KS: Autism Asperger Publishing Co.
Minshew, N. J., & Williams, D. L. (2007). The new neurobiology of autism: Cortex,
connectivity, and neuronal organization. Archives of Neurology, 64, 645-950. doi:
10.1001/archneur.64.7.94
Moser, J. S., Hajcak, G., & Simons, R. F. (2005). The effects of fear on performance monitoring
and attentional allocation. Psychophysiology, 42, 261-268. doi: 10.1111/j.14698986.2005.00290.x
Moser, J. S., Moran, T. P., Schroder, H. S., Donnellan, M. B., & Yeung, N. (2013). On the
relationship between anxiety and error monitoring: A meta-analysis and conceptual
framework. Frontiers in Human Neuroscience, 7, 1-19. doi: 10.3389/fnhum.2013.00466

87
Nieuwenhuis, S., Ridderinkhof, K. R., Blom, J., Band, G. P., & Kok, A. (2001). Error-related
brain potentials are differentially related to awareness of response errors: Evidence from
an antisaccade task. Psychophysiology, 38, 752-760. doi: 10.1111/1469-8986.3850752
Noriuchi, M., Kikuchi, Y., Yoshiura, T., Kira, R., Shigeto, H., Hara, T., . . . Kamio, Y. (2010).
Altered white matter fractional anisotropy and social impairment in children with autism
spectrum disorder. Brain Research, 1362, 141-149. doi: 10.1016/j.brainres.2010.09.051
Nydén, A., Hagberg, B., Goussé, V., & Rastam, M. (2011). A cognitive endophenotype of
autism in families with multiple incidence. Research in Autism Spectrum Disorders, 5,
191-200. doi: 10.1016/j.rasd.2010.03.010
O’Connell, R. G., Bellgrove, M. A., Dockree, P. M., Lau, A., Hester, R., Garavan, H., . . .
Robertson, I. H. (2009). The neural correlates of deficient error awareness in attentiondeficit hyperactivity disorder (ADHD). Neuropsychologia, 47, 1149-1159. doi:
10.1016/j.neuropsychologia.2009.01.011
Olvet, D. M., & Hajcak, G. (2008). The error-related negativity (ERN) and psychopathology:
Toward an endophenotype. Clinical Psychology Review, 28, 1343-1354. doi:
10.1016/j.cpr.2008.07.003
Olvet, D. M., & Hajcak, G. (2009a). The effect of trial-to-trial feedback on the error-related
negativity and its relationship with anxiety. Cognitive Affective and Behavioral
Neuroscience, 9, 427-433. doi: 10.3758/cabn.9.4.427
Olvet, D. M., & Hajcak, G. (2009b). The stability of error-related brain activity with increasing
trials. Psychophysiology, 46, 957-961. doi: 10.1111/j.1469-8986.2009.00848.x

88
Olvet, D. M., & Hajcak, G. (2012). The error-related negativity relates to sadness following
mood induction among individuals with high neuroticism. Social Cognitive and Affective
Neuroscience, 7, 289-295. doi: 10.1093/scan/nsr007
Olvet, D. M., Klein, D. N., & Hajcak, G. (2010). Depression symptom severity and error-related
brain activity. Psychiatry Research, 179, 30-37. doi: 10.1016/j.psychres.2010.06.008
Orekhova, E. V., Stroganova, T. A., Nygren, G., Tsetlin, M. M., Posikera, I. N., Gillberg, C., &
Elam, M. (2007). Excess of high frequency electroencephalogram oscillations in boys
with autism. Biological Psychiatry, 62, 1022-1029. doi: 10.1016/j.biopsych.2006.12.029
Overbeek, T. J. M., Nieuwenhuis, S., & Ridderinkhof, K. R. (2005). Dissociable components of
error processing: On the functional significance of the Pe vis-à-vis the ERN/Ne. Journal
of Psychophysiology, 19, 319-329. doi: 10.1027/0269-8803.19.4.319
Ozonoff, S., Pennington, B. F., & Rogers, S. J. (1991). Executive function deficits in highfunctioning autistic indificuals: Relationship to theory of mind. Journal of Child
Psychology and Psychiatry, 32, 1080-1105. doi: 10.1111/j.1469-7610.1991.tb00351.x
Ozonoff, S., Rogers, S. J., Farnham, J. M., & Pennington, B. F. (1993). Can standard measures
identify subclinical markers of autism? Journal of Autism and Developmental Disorders,
23, 429-441. doi: 10.1007/BF01046049
Ozonoff, S., Young, G. S., Carter, A., Messinger, D., Yirmiya, N., Zwaigenbaum, L., . . . Stone,
W. L. (2011). Recurrence risk for autism spectrum disorders: A baby siblings research
consortium study. Pediatrics, 128, 488-495. doi: 10.1542/peds.2010-2825
Pailing, P. E., & Segalowitz, S. J. (2004). The error-related negativity as a state and trait
measure: Motivation, personality, and ERPs in response to errors. Psychophysiology, 41,
84-95. doi: 10.1111/1469-8986.00124

89
Peterson, E., Schmidt, G. L., Tregellas, J. R., Winterrowd, E., Kopelioff, L., Hepburn, S., . . .
Rojas, D. C. (2006). A voxel-based morphometry study of gray matter in parents of
children with autism. Neuroreport, 21, 1289-1292. doi:
10.1097/01.wnr.0000233087.15710.87
Pickles, A., Starr, E., Kazak, S., Bolton, P., Bailey, A., Goodman, R., & Rutter, M. (2000).
Variable expression of the autism broader phenotype: Findings from extended pedigrees.
Journal of Child Psychology and Psychiatry, 41, 491-502. doi: 10.1111/1469-7610.00634
Piven, J., Gayle, J., Chase, G. A., Fink, B., Landa, R., Wzorke, M. M., & Folstein, S. (1990). A
family history study of neuropsychiatric disorders in the adult siblings of autistic
individuals. Journal of the American Academy of Child and Adolescent Psychiatry, 29,
177-184. doi: 10.1097/00004583-199003000-00004
Proudfit, G. H., Inzlicht, M., & Mennin, D. S. (2013). Anxiety and error monitoring: The
importance of motivation and emotion. Frontiers in Human Neuroscience 7, 636. doi:
10.3389/fnhum.2013.00636
Razali, N. M., & Wah, Y. B. (2011). Power comparisons of Shapiro-Wilk, KolmogorovSmirnov, Lilliefors and Anderson-Darlling tests. Journal of Statistical Modeling and
Analytics 2, 21-22.
Redcay, E., & Courchesne, E. (2005). When is the brain enlarged in autism? A meta-analysis of
all brain size reports. Biological Psychiatry, 58, 1-9. doi: 10.1016/j.biopsych.2005.03.026
Riba, J., Rodriguez-Fornells, A., Münte, T. F., & Barbanoj, M. J. (2005). A neurophysiological
study of the detrimental effects of alprazolam on human action monitoring. Cognitive
Brain Research, 25, 554-565. doi: 10.1016/j.cogbrainres.2005.08.009

90
Ridderinkhof, K. R., van der Molen, M. W., Band, G. P., & Bashore, T. R. (1997). Sources of
interference from irrelevant information: A developmental study. Journal of
Experimental Child Psychology, 65, 315-341. doi: 10.1006/jecp.1997.2367
Riesel, A., Endrass, T., Kaufmann, C., & Kathmann, N. (2011). Overactive error-related brain
activity as a candidate endophenotype for obsessive-compulsive disorder: Evidence from
unaffected first-degree relatives. The American Journal Of Psychiatry, 168, 317-324. doi:
10.1176/appi.ajp.2010.10030416
Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, L., . . . Myers, R. M.
(1999). A genomic screen of autism: Evidence for a multilocus etiology. American
Journal of Human Genetics, 65, 493-507. doi: 10.1086/302497
Ritsner, M. S., & Gottesman, I. I. (2009). Where do we stand in the quest for neuropsychiatric
biomarkers and endophenotypes and what next? In M. S. Ritsner (Ed.), The handbook of
neuropsychiatric biomarkers, endophenotypes and genes (Vol. 1, pp. 3-21). Berlin:
Springer Netherlands.
Ronald, A., & Hoeksma, M. R. (2010). Autism spectrum disorders and autistic traits: A decade
of new twin studies. American Journal of Medical Genetics Part B: Neuropsychiatric
Genetics 156, 255-274. doi: 10.1002/ajmg.b.31159
Rosenberg, R. E., Law, J. K., Yenokyan, G., McGready, J., Kaufmann, W. E., & Law, P. A.
(2009). Characteristics and concordance of autism spectrum disorders among 277 twin
pairs. Archives of Pediatrics and Adolescent Medicine, 163, 907-914. doi:
10.1001/archpediatrics.2009.98

91
Ruchsow, M., Grön, G., Reuter, K., Spitzer, M., Hermle, L., & Kiefer, M. (2005). Error-related
brain activity in patients with obsessive-compulsive disorder and in healthy controls.
Journal of Psychophysiology, 19, 298-304. doi: 10.1027/0269-8803.19.4.298
Ruchsow, M., Herrnberger, B., Beschoner, P., Gron, G., Spitzer, M., & Kiefer, M. (2006). Error
processing in major depressive disorder: Evidence from event-related potentials. Journal
of Psychiatric Research, 40, 37-46. doi: 10.1016/j.jpsychires.2005.02.002
Ruchsow, M., Reuter, K., Hermle, L., Ebert, D., Kiefer, M., & Falkenstein, M. (2007). Executive
control in obsessive-compulsive disorder: Event-related potentials in a Go/Nogo task.
Journal of Neural Transmission, 114, 1595-1601. doi: 10.1007/s00702-007-0779-4
Rueda, M. R., Fan, J., McCandliss, B. D., Halparin, J. D., Gruber, D. B., Lercari, L. P., & Poster,
M. I. (2004). Development of attentional networks in childhood. Neuropsychologia, 42,
1029-1040. doi: 10.1016/j.neuropsychologia.2003.12.012
Ruser, T. F., Arin, D., Dowd, M., Putnam, S., Winklosky, B., Rosen-Sheidley, B., . . . Folstein,
S. (2007). Communicative competence in parents of children with autism and parents of
children with specific language impairment. Journal of Autism and Developmental
Disorders, 2007, 1323-1336. doi: 10.1007/s10803-006-0274-z
Sahyoun, C. P., Belliveau, J. W., Soulières, I., Schwartz, S., & Mody, M. (2010). Neuroimaging
of the functional and structural networks underlying visuospatial vs. linguistic reasoning
in high-funcitoning autism. Neuropsychologia, 48, 86-95. doi:
10.1016/j.neuropsychologia.2009.08.013
Santesso, D. L., Drmic, I. E., Jetha, M. K., Bryson, S. E., Goldberg, J. O., Hall, G. B., . . .
Schmidt, L. A. (2011). An event-related source localization study of response monitoring

92
and social impairments in autism spectrum disorder. Psychophysiology, 48, 241-251. doi:
10.1111/j.1469-8986.2010.01056.x
Santesso, D. L., Segalowitz, S. J., & Schmidt, L. A. (2006). Error-related electrocortical
responses in 10-year-old children and young adults. Developmental Science, 9, 473-481.
doi: 10.1111/j.1467-7687.2006.00514.x
Sasson, N. J., Lam, K. S., Childress, D., Parlier, M., Daniels, J. L., & Piven, J. (2013). The Broad
Autism Phenotype Questionnaire: Prevalance and diagnostic classification. Autism
Research, 6, 134-143. doi: 10.1002/aur.1272
Schipul, S. E., Williams, D. L., Keller, T. A., Minshew, N. J., & Just, M. A. (2012). Distinctive
neural processes during learning in autism. Cerebral Cortex, 22, 937-950. doi:
10.1093/cercor/bhr162
Schoenberg, P. L. A., Hepark, S., Kan, C. C., Barendregt, H. P., Buitelaar, J. K., & Speckens, A.
E. M. (2014). Effects of mindfulness-based cognitive therapy on neurophysiological
correlates of performance monitoring in adult attention-deficit/hyperactivity disorder.
Clinical Neurophysiology, 125, 1407-1416. doi: 10.1016/j.clinph.2013.11.031
Segalowitz, S. J., & Dywan, J. (2009). Individual differences and developmental change in the
ERN response: Implications for models of ACC function Psychological Research, 73,
857-870. doi: 10.1007/s00426-008-0193-z
Seidman, I., Yirmiya, N., Milshtein, S., Ebstein, R. P., & Levi, S. (2011). The Broad Autism
Phenotype Questionnaire: Mothers versus fathers of children with autism spectrum
disorder Journal of Autism and Developmental Disorders, 42, 837-846. doi:
10.1007/s10803-011-1315-9

93
Simmonite, M., Bates, A. T., Groom, M. J., Jackson, G. M., Hollis, C., & Liddle, P. F. (2012).
Error processing-associated event-related potentials in schizophrenia and unaffected
siblings. International Journal of Psychophysiology, 84, 74-79. doi:
10.1016/j.ijpsycho.2012.01.012
Simms, M. L., Kemper, T. L., Timbie, C. M., Bauman, M. L., & Blatt, G. L. (2009). The anterior
cingulate cortex in autism: Heterogeneity of qualitative and quantitative cytoarchitectonic
features suggests possible subgroups Acta Neuropathologica, 118, 673-684. doi:
10.1007/s00401-009-0568Sokhadze, E., Baruth, J., El-Baz, A., Horrell, T., Sokhadze, G., Carroll, T., . . . Casanova, M. F.
(2010). Impaired error monitoring and correction funciton in autism. Journal of
Neurotherapy, 14, 79-95. doi: 10.1080/10874201003771561
Sokhadze, E., Baruth, J., Sears, L., Sokhadze, G., El-Baz, A., Williams, E., . . . Casanova, M. F.
(2012). Event-related potential study of attention regulation during illusory figure
categorization task in ADHD, autism spectrum disorder, and typical children. Journal of
Neurotherapy, 16, 12-31. doi: 10.1080/10874208.2012.650119
Sokhadze, E. M., El-Baz, A. S., Sears, L. L., Opris, I., & Casanova, M. F. (2014). rTMS
neuromodulation improves electrocortical functional measures of information processing
and behavioral responses in autism. Frontiers in Systems Neuroscience, 8, 134. doi:
10.3389/fnsys.2014.00134
South, M., Larson, M. J., Krauskopf, E., & Clawson, A. (2010). Error processing in highfunctioning Autism Spectrum Disorders. Biological Psychology, 85, 242-251. doi:
10.1016/j.biopsycho.2010.07.009

94
Spielberger, C. D., Gorusch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for
the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
StataCorp. (2013). Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.
Steinhauser, M., & Yeung, N. (2010). Decision processes in human performance monitoring.
Journal of Neuroscience, 30, 15643-15653. doi: 10.1523/jneurosci.1899-10.2010
Strimbu, K., & Tavel, J. A. (2010). What are biomarkers? Current Opinion in HIV and AIDS, 5,
463-466. doi: 10.1097/COH.0b013e32833ed177
Sucksmith, E., Roth, I., & Hoekstra, R. A. (2011). Autistic traits below the clinical threshold:
Re-examining the broader autism phenotype in the 21st Century. Neuropsychology
Review, 21, 360-389. doi: 10.1007/s11065-011-9183-9
Sumiyoshi, C., Kawakubo, Y., Suga, M., Sumiyoshi, T., & Kasai, K. (2011). Impaired ability to
organize information in individuals with autism spectrum disorders and their siblings.
Neuroscience Research, 69, 252-257. doi: 10.1016/j.neures.2010.11.007
Sutcliffe, J. S., Han, M. H., Amin, T., Kesterson, R. A., & Nurmi, E. L. (2003). Partial
duplication of hte APBA2 gene in chromosome 15q13 corresponds to duplicon
structures. BMC Genomics, 4, 1-11. doi: 10.1186/1471-2164-4-15
Szatmari, P., & Jones, M. B. (1998). Genetic epidemiology of autism and pervasive
developmental disorders. In F. R. Volkmar (Ed.), Autism and Pervasive Developmental
Disorders (pp. 109-129). Cambridge Cambridge University Press.
Thakkar, K. N., Polli, F. E., Joseph, R. M., Tuch, D. S., Hadjikhani, N., Barton, J. J. S., &
Manoach, D. S. (2008). Response monitoring, repetitive behaviour and anterior cingulate
abnormalities in autism spectrum disorders (ASD). Brain, 131, 2464-2478. doi:
10.1093/brain/awn099

95
van Veen, V., & Carter, C. S. (2002a). The anterior cingulate as a conflict monitor: fMRI and
ERP studies. Physiology & Behavior, 77, 477-482. doi: 10.1016/S0031-9384(02)00930-7
van Veen, V., & Carter, C. S. (2002b). The timing of action-monitoring processes in the anterior
cingulate cortex. Journal of Cognitive Neuroscience, 14, 593-602. doi:
10.1162/08989290260045837
Vasa, R. A., & Mazurek, M. O. (2015). An update on anxiety in youth with autism spectrum
disorders. Current Opinion in Psychiatry, 28, 83-90. doi:
10.1097/YCO.0000000000000133
Vidal, F., Hasbroucq, T., Grapperon, J., & Bonnet, M. (2000). Is the 'error negativity' specific to
errors? Biological Psychology, 51, 109-128. doi: 10.1016/s0301-0511(99)00032-0
Viding, E., & Blakemore, S. J. (2007). Endophenotype approach to developmental
psychopathology: Implications for autism research. Behavioral Genetics, 37, 51-60. doi:
10.1007/s10519-006-9105-4
Vlamings, P. H. J. M., Jonkman, L. M., Hoeksma, M. R., van Engeland, H., & Kemner, C.
(2008). Reduced error monitoring in children with autism spectrum disorder: An ERP
study. European Journal of Neuroscience, 28, 399-406. doi: 10.1111/j.14609568.2008.06336.x
Volkmar, F., & McPartland, J. C. (2014). From Kanner to DSM-5: Autism as an evolving
diagnostic concept. Annual Review of Clinical Psychology 10, 193-212. doi:
10.1146/annurev-clinpsy-032813-153710
Volkmar, F. R., & Reichow, B. (2013). Autism in DSM-5: Progress and challenges. Molecular
Autism, 4, 13. doi: 10.1186/2040-2392-4-13

96
Wang, A. T., Dapretto, M., Hariri, A. R., Sigman, M., & Bookheimer, S. Y. (2004). Neural
correlates of facial affect processing in children and adolescents with autism spectrum
disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 481490. doi: 10.1097/00004583-200404000-00015
Wass, S. (2011). Distortions and disconnections: Disrupted brain connectivity in autism. Brain
and Cognition, 75, 18-28. doi: 10.1016/j.bandc.2010.10.005
Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence. New York, NY: The
Psychological Corporation: Harcourt Brace & Company.
Weinberg, A., Olvet, D. M., & Hajcak, G. (2010). Increased error-related brain activity in
generalized anxiety disorder. Biological Psychology, 85, 472-480. doi:
10.1016/j.biopsycho.2010.09.011
Wheelright, S., Auyeung, B., Allison, C., & Baron-Cohen, S. (2010). Defining the broader,
medium and narrow autism phenotype among parents using the Autism Spectrum
Quotient (AQ). Molecular Autism, 1, 10. doi: 10.1186/2040-2392-1-10
Wiersema, J. R., van der Meere, J. J., & Roeyers, H. (2007). Developmental changes in error
monitoring: An event-related potential study. Neuropsychologia, 45, 1649-1657. doi:
10.1016/j.neuropsychologia.2007.01.004
Wong, D., Maybery, M., Bishop, D. V. M., Maley, A., & Hallmayer, J. (2006). Profiles of
executive function in parents and siblings of individuals with autism spectrum disorders.
Genes, Brain and Behavior, 5, 561-576. doi: 10.1111/j.1601-183X.2005.00199.x
Yeung, N., Botvinick, M. M., & Cohen, J. D. (2004). The neural basis of error detection:
Conflict monitoring and the error-related negativity. Psychological Review, 111, 931959. doi: 10.1037/0033-295x.111.4.931

97
Yeung, N., & Cohen, J. D. (2006). The impact of cognitive deficits on conflict monitoring.
Predictable dissociations between the error-related negativity and N2. Psychological
Science, 17, 164-171. doi: 10.1111/j.1467-9280.2006.01680.x
Zikopoulos, B., & Barbas, H. (2010). Changes in prefrontal axons may disrupt the network in
autism. Journal of Neuroscience, 30, 14595-14609. doi: 10.1523/JNEUROSCI.225710.2010

